JPH0272873A - Nucleosideoxidase and analyzing method utilizing the same - Google Patents
Nucleosideoxidase and analyzing method utilizing the sameInfo
- Publication number
- JPH0272873A JPH0272873A JP63196632A JP19663288A JPH0272873A JP H0272873 A JPH0272873 A JP H0272873A JP 63196632 A JP63196632 A JP 63196632A JP 19663288 A JP19663288 A JP 19663288A JP H0272873 A JPH0272873 A JP H0272873A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- nucleoside
- nucleosides
- reaction
- inosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108030001010 Nucleoside oxidases Proteins 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims description 20
- 239000002777 nucleoside Substances 0.000 claims abstract description 70
- 230000000694 effects Effects 0.000 claims abstract description 50
- 125000003835 nucleoside group Chemical group 0.000 claims abstract description 46
- 150000003833 nucleoside derivatives Chemical class 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 22
- 238000004458 analytical method Methods 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims description 110
- 108090000790 Enzymes Proteins 0.000 claims description 110
- 238000006243 chemical reaction Methods 0.000 claims description 44
- 238000012360 testing method Methods 0.000 claims description 31
- 238000007254 oxidation reaction Methods 0.000 claims description 23
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 21
- 239000003153 chemical reaction reagent Substances 0.000 claims description 20
- 239000012085 test solution Substances 0.000 claims description 19
- 238000004040 coloring Methods 0.000 claims description 17
- 238000006911 enzymatic reaction Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 238000011161 development Methods 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 8
- 108010028584 nucleotidase Proteins 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 229910001882 dioxygen Inorganic materials 0.000 claims description 4
- 229960003786 inosine Drugs 0.000 abstract description 45
- 229930010555 Inosine Natural products 0.000 abstract description 44
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 abstract description 44
- 238000002360 preparation method Methods 0.000 abstract description 16
- 244000005700 microbiome Species 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 abstract description 10
- 241000122973 Stenotrophomonas maltophilia Species 0.000 abstract description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 abstract description 8
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 abstract description 7
- 239000000872 buffer Substances 0.000 abstract description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 abstract description 6
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 abstract description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract description 3
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 abstract description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 abstract description 3
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 abstract description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 2
- 229940028843 inosinic acid Drugs 0.000 abstract description 2
- 235000013902 inosinic acid Nutrition 0.000 abstract description 2
- 239000004245 inosinic acid Substances 0.000 abstract description 2
- 230000007935 neutral effect Effects 0.000 abstract description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229960004838 phosphoric acid Drugs 0.000 abstract 1
- 235000011007 phosphoric acid Nutrition 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 107
- 239000000243 solution Substances 0.000 description 30
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 26
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 22
- 239000000758 substrate Substances 0.000 description 22
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 20
- 238000002835 absorbance Methods 0.000 description 19
- 239000008363 phosphate buffer Substances 0.000 description 19
- 108010029541 Laccase Proteins 0.000 description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 239000001301 oxygen Substances 0.000 description 16
- 238000005259 measurement Methods 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 102000004008 5'-Nucleotidase Human genes 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 108010043671 prostatic acid phosphatase Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 7
- 229960005305 adenosine Drugs 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- 230000036284 oxygen consumption Effects 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- HAEJPQIATWHALX-KQYNXXCUSA-N ITP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 HAEJPQIATWHALX-KQYNXXCUSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 5
- 238000011481 absorbance measurement Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 238000000691 measurement method Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- AEOBEOJCBAYXBA-UHFFFAOYSA-N A2P5P Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1OP(O)(O)=O AEOBEOJCBAYXBA-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 4
- 108010053835 Catalase Proteins 0.000 description 4
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 4
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940029575 guanosine Drugs 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000001008 quinone-imine dye Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010037497 3'-nucleotidase Proteins 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000012506 Sephacryl® Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229950006790 adenosine phosphate Drugs 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 238000002525 ultrasonication Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 229930190128 Xanthomonadin Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 etc. Proteins 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000000852 hydrogen donor Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000004060 quinone imines Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- HOLHYSJJBXSLMV-UHFFFAOYSA-N 2,6-dichlorophenol Chemical compound OC1=C(Cl)C=CC=C1Cl HOLHYSJJBXSLMV-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- LNQVTSROQXJCDD-KQYNXXCUSA-N 3'-AMP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O LNQVTSROQXJCDD-KQYNXXCUSA-N 0.000 description 1
- JDRFUUBRGGDEIZ-UHFFFAOYSA-N 3,6-dichloro-2-methoxybenzoate;dimethylazanium Chemical compound CNC.COC1=C(Cl)C=CC(Cl)=C1C(O)=O JDRFUUBRGGDEIZ-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- NZAVBNVWEPQSBL-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical class OS(=O)(=O)CCCN(CC)C1=CC(OC)=CC(OC)=C1 NZAVBNVWEPQSBL-UHFFFAOYSA-N 0.000 description 1
- NPROGRQJOGOVDS-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC(C)=CC(C)=C1 NPROGRQJOGOVDS-UHFFFAOYSA-N 0.000 description 1
- ZTQGWROHRVYSPW-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZTQGWROHRVYSPW-UHFFFAOYSA-N 0.000 description 1
- LHZMSRLULDAWLM-UHFFFAOYSA-N 3-(n-ethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC=C1 LHZMSRLULDAWLM-UHFFFAOYSA-N 0.000 description 1
- HXITYOAFXWBMLL-UHFFFAOYSA-N 3-(n-ethylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC=C1 HXITYOAFXWBMLL-UHFFFAOYSA-N 0.000 description 1
- XSRCFFDUTPZZHD-UHFFFAOYSA-N 3-methyl-2h-1,3-benzothiazole 1-oxide Chemical compound C1=CC=C2N(C)CS(=O)C2=C1 XSRCFFDUTPZZHD-UHFFFAOYSA-N 0.000 description 1
- WNFFLHJDFSCVLI-UHFFFAOYSA-N 4-isoquinolin-3-ylbutanenitrile Chemical compound C1=CC=C2C=NC(CCCC#N)=CC2=C1 WNFFLHJDFSCVLI-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100215617 Arabidopsis thaliana ADO3 gene Proteins 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920002491 Diethylaminoethyl-dextran Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101150096839 Fcmr gene Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000001585 disappearance potential spectroscopy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- MWFOPMKUGZLPQA-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 MWFOPMKUGZLPQA-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、ヌクレオシドの酸化反応を触媒する新しい酵
素、詳しくはヌクレオシドと分子状酸素との反応によっ
てヌレオシド−5′−アルデヒドを経てヌクレオシド−
5′−カルボン酸を生成するが、過酸化水素は副生じな
い新規ヌクレオシドオキシダーゼYT−1及び該酵素を
利用した新規な分析法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention is directed to a new enzyme that catalyzes the oxidation reaction of nucleosides, specifically, to oxidize nucleosides through the reaction of nucleosides with molecular oxygen to form nucleosides-5'-aldehydes.
The present invention relates to a novel nucleoside oxidase YT-1 that produces 5'-carboxylic acid but does not produce hydrogen peroxide as a by-product, and a novel analytical method using this enzyme.
従来の技術
ヌクレオシドに作用する酵素としては、その加水分解酵
素や脱アミノ酵素と共に、次式に示される酸化反応を触
媒する酵素(ヌクレオシドオキシダーゼ)が知られてい
る。BACKGROUND OF THE INVENTION As enzymes that act on nucleosides, an enzyme (nucleoside oxidase) that catalyzes the oxidation reaction shown by the following formula is known, as well as hydrolase and deaminase.
上記ヌクレオシドオキシダーゼは、従来より例えば代表
的にはシュードモナス・プチダ(Pseudomona
s putida)等の微生物から単離、精製され、ヌ
クレオシド−5′−カルボン酸類の製造や、ヌクレオシ
ド類の字母、更には反応によってヌクレオシドが生成し
たり減少したりする酵素類の活性測定系等に種々利用さ
れている。The above-mentioned nucleoside oxidase has conventionally been typically used, for example, in Pseudomonas putida (Pseudomonas putida).
It is isolated and purified from microorganisms such as P. sputida, and is used for the production of nucleoside-5'-carboxylic acids, the expression of nucleosides, and the activity measurement system of enzymes that generate or decrease nucleosides through reactions. It is used in various ways.
しかるに、上記オキシダーゼの利用によれば酸化反応系
においてH2O2の発生が必然的に起こり、例えば上記
ヌクレオシド−5′−カルボン酸類の製造においては、
反応系にカタラーゼ等を添加して上記H2O2を分解さ
せる必要があり、また上記反応系内に生成するH2 o
2ffiの測定によってヌクレオシドを測定、定量する
方法では、パーオキシダーゼの利用が必須となる不利が
ある。However, the use of the oxidase inevitably generates H2O2 in the oxidation reaction system, and for example, in the production of the nucleoside-5'-carboxylic acids,
It is necessary to add catalase etc. to the reaction system to decompose the above H2O2, and the H2O2 generated in the above reaction system
The method of measuring and quantifying nucleosides by measuring 2ffi has the disadvantage of requiring the use of peroxidase.
しかも上記測定法では、測定系が繁雑となる等の弊害が
ある(例えば特開昭57−58883号公報、特開昭5
7−68794号公報、特開昭57−94300号公報
等参照)。Moreover, the above measurement method has disadvantages such as a complicated measurement system (for example, Japanese Patent Application Laid-Open No. 57-58883;
7-68794, JP-A-57-94300, etc.).
発明が解決しようとする問題点
本発明者らは、以前から各種微生物起源等のヌクレオシ
ドオキシダーゼにつき、鋭意研究を重ねてきたが、その
過程で、新たに土壌から単離したシュードモナス属に属
する一菌株が、従来のヌクレオシドオキシダーゼとは異
なる酸化反応を触媒する酵素の産生能を有することを見
出すと共に、該酵素の単離精製、その性質等の解明に成
功し、更に該酵素の利用による新しい分析、測定技術の
開発にも成功し、ここに本発明を完成するに至った。Problems to be Solved by the Invention The present inventors have been conducting extensive research on nucleoside oxidases originating from various microorganisms, and in the process, they discovered a strain belonging to the genus Pseudomonas that was newly isolated from soil. discovered that it has the ability to produce an enzyme that catalyzes an oxidation reaction different from that of conventional nucleoside oxidases, and also succeeded in isolating and purifying the enzyme and elucidating its properties. They also succeeded in developing a measurement technique, which led to the completion of the present invention.
問題点を解決するための手段
即ち、本発明はヌクレオシドの酸化反応を触媒する酵、
素であって、該ヌクレオシドと分子状酸素との反応によ
ってヌレオシド−5′−アルデヒドを経てヌクレオシド
−5′−カルボン酸を生成するが、過酸化水素は副生し
ないことを特徴とする新規ヌクレオシドオキシダーゼY
T−1、並びにヌクレオシドを含有するか又はこれを生
成させる系を被検液とし、酸化により発色する発色試薬
と上記被検液との混合物に上記ヌクレオシドオキシダー
ゼYT−1を作用させ、被検液のヌクレオシド母変化に
比例する上記発色試薬の発色度合を測定することを特徴
とする被検液の分析法に係わる。Means for solving the problem, that is, the present invention provides an enzyme that catalyzes the oxidation reaction of nucleosides.
A novel nucleoside oxidase, which produces nucleoside-5'-carboxylic acid via nucleoside-5'-aldehyde through the reaction of the nucleoside with molecular oxygen, but does not produce hydrogen peroxide as a by-product. Y
T-1 and a system containing or producing nucleosides are used as test solutions, and the nucleoside oxidase YT-1 is applied to a mixture of the above test solution and a coloring reagent that develops color by oxidation, and the test solution is The present invention relates to a method for analyzing a test liquid, characterized in that the degree of color development of the color reagent described above is measured in proportion to the change in the nucleoside base.
本発明酵素の触媒する上記ヌクレオシドの酸化反応は、
次式(1)及び(2)で示され、これまで知られている
ヌクレオシドオキシダーゼの酸化反応とは明確に区別さ
れる。勿論、従来かかる式(1)及び(2)で示される
反応を触媒するヌクレオシドオキシダーゼは全く知られ
ていない。The nucleoside oxidation reaction catalyzed by the enzyme of the present invention is:
It is shown by the following formulas (1) and (2), and is clearly distinguished from the oxidation reactions of nucleoside oxidases known so far. Of course, there have been no known nucleoside oxidases that catalyze the reactions represented by formulas (1) and (2).
また、本発明のヌクレオシドオキシダーゼYT−1は、
後記に詳述する通り、上記式で示される該ヌクレオシド
の酸化反応と同時に、該ヌクレオシド量に応じてラッカ
ーゼ様活性を示すという該酵素に特有の性質を有してお
り、この点においても従来のヌクレオシドオキシダーゼ
とは全く異なっている。本発明の分析法は、該酵素に特
有の上記ラッカーゼ様活性を利用して、発色試薬の発色
度合を例えば吸光度llす定により行なうものであり、
従来のヌクレオシドオキシダーゼの利用では、かる分析
は実施できない。Furthermore, the nucleoside oxidase YT-1 of the present invention is
As will be explained in detail later, the enzyme has the unique property of exhibiting laccase-like activity depending on the amount of the nucleoside at the same time as the oxidation reaction of the nucleoside represented by the above formula; It is completely different from nucleoside oxidase. The analytical method of the present invention utilizes the laccase-like activity specific to the enzyme to determine the degree of color development of a color reagent, for example, by determining the absorbance.
Such an analysis cannot be performed using conventional nucleoside oxidases.
以下、本発明酵素の製造法、その性質及びこれを利用し
た本発明の分析法につき順次説明する。Hereinafter, the method for producing the enzyme of the present invention, its properties, and the analytical method of the present invention using the same will be sequentially explained.
本発明酵素は、シュードモナス属に属する該酵素生産菌
を用いて製造できる。ここで用いられる上記酵素の生産
菌としては、例えば本発明者らが新たに単離した以下の
性質を有する菌株を例示できる。The enzyme of the present invention can be produced using the enzyme-producing bacterium belonging to the genus Pseudomonas. Examples of the enzyme-producing bacteria used here include a strain newly isolated by the present inventors and having the following properties.
■、菌学的性質
(A)形態学的性質
■ 細胞は桿菌であり、大きさは0. 5X1. 5〜
1.7μmである。■, Mycological properties (A) Morphological properties ■ The cells are bacilli, and the size is 0. 5X1. 5~
It is 1.7 μm.
■ 運動性を有し、べん毛は極べん毛である。■ It is motile and the flagella are extremely flagella.
■ 胞子は形成されない。■ Spores are not formed.
■ ダラム染色においては陰性である。■ Negative in Durham staining.
(B)培養所見
■ 肉汁寒天平板培養
生育は中庸であり、集落は円形で、表面は滑かで黄色で
ある。(B) Culture findings■ Growth on broth agar plate is moderate, colonies are circular, and the surface is smooth and yellow.
■ 肉汁寒天斜面培養 生育は中庸であり、表面は滑かで黄色である。■ Meat juice agar slant culture The growth is moderate and the surface is smooth and yellow.
■ 肉、汁液体培養 表面に生育し、生育は中庸である。■ Meat, juice liquid culture It grows on the surface and its growth is moderate.
■ 肉汁ゼラチン穿刺培養
表面部分に生育し、ゼラチンを液化する(Strati
form)。■ Meat juice gelatin puncture culture grows on the surface and liquefies gelatin (Strati
form).
(C)生理的性質
■ 硝酸塩の還元 陰性
■ 脱窒反応 陰性
■ インドールの生成 陰性
■ 硫化水素の生成 陰性
■ 澱粉の加水分解 陰性
■ 硝酸塩の利用 陰性
■ アンモニウム塩の利用 陽性
■ 色素の生成
蛍光色素、ビオシアニン、キサントモナジンはいずれも
生成しない。肉汁寒天培地では褐色の拡散性色素を生産
することがある。(C) Physiological properties ■ Nitrate reduction Negative ■ Denitrification reaction Negative ■ Indole formation Negative ■ Hydrogen sulfide formation Negative ■ Starch hydrolysis Negative ■ Nitrate utilization Negative ■ Ammonium salt utilization Positive ■ Pigment production Fluorescent dye , biocyanin, and xanthomonadin are not produced. Broth agar may produce a brown, diffusible pigment.
■ ウレアーゼ 陰性
[株] オキシダーゼ 陰性〜四隅性■ カタ
ラーゼ 陽性
■ 生育の範囲
pH4,5で生育しない。4°C及び41℃で生育しな
い。生育pHは5〜8の範囲が適当であり、温度は35
℃が最適である。■ Urease negative [strain] Oxidase negative to four-sided ■ Catalase positive ■ Growth range: Does not grow at pH 4 or 5. Does not grow at 4°C and 41°C. The appropriate growth pH is between 5 and 8, and the temperature is 35.
°C is optimal.
0 酸素に対する態度 好気性である■ 0−Fテス
ト(Hugh Leifson法) 酸化的■ 糖類か
らの酸の生成
り−グルコース 陽性
D−フルクトース 陽性
D−マルトース 陽性
D−ガラクトース 陽性
D−キシロース 陽性
D−マンニトール 陰性
ショ糖 陰性
乳 糖 陽性
@ エスクリンの分解 陽性0 ア、ルギ
ニンジヒドラーゼ 陰性@ リジンデカルボキシ
ラーゼ 陽性0 オルニチンデカルボキシラーゼ
陰性[相] フェニルアラニンデアミナーゼ 陰性■
卵黄反応 陰性■ ツイーン20
の分解 陽性■ ツイーン80の分解
陽性[相] ポリベーターヒドロキシ酪酸の蓄積
陰性[相] 栄養要求性
メチオニン或いはシスチンを要求する。0 Attitude towards oxygen Aerobic ■ 0-F test (Hugh Leifson method) Oxidative ■ Production of acid from sugars - glucose Positive D-fructose Positive D-maltose Positive D-galactose Positive D-xylose Positive D-mannitol Negative sucrose Negative Lactose Positive @ Aesculin degradation Positive 0 A, Luginine dihydrase Negative @ Lysine decarboxylase Positive 0 Ornithine decarboxylase
Negative [phase] Phenylalanine deaminase negative■
Egg yolk reaction negative ■ Tween 20
Decomposition of positive ■ Decomposition of Tween 80
Positive [phase] Accumulation of polybator hydroxybutyrate Negative [phase] Requires auxotrophic methionine or cystine.
以上の各性質をもとに、本菌株の検索をパージ(Bcr
gcy’s Manual of Systemati
c Bacteriology(1984))に従って
行なうと、本菌株は■グラム陰性の桿菌であり、胞子を
形成しないこと、■カタラーゼ陽性であること、■極べ
ん毛で運動すること、■グルコースを酸化的に分解する
こと、■pH7,0の普通寒天培地によく生育すること
等の特徴を有していることより、シュードモナス属(P
seudomonas属)に属すると認められた。更に
■シスチン或いはメチオニンを生育に要求すること、■
アルギニンジヒドロラーゼ陰性であること、■ポリベー
ターヒドロキシ酪酸を蓄積しないこと、■コロニーが黄
色であること、■キサントモナジンを産生じないこと、
■オキシダーゼ反応が微弱であること等、シュードモナ
ス マルトフィリア(Pseudomonas mal
tophilia )の特徴とよく一致した。Based on the above properties, we searched for this strain by purging (Bcr
gcy's Manual of Systemati
According to C Bacteriology (1984)), this strain is: ■ Gram-negative rod and does not form spores; ■ It is catalase positive; ■ It moves by ultraflagella; and ■ It does not oxidize glucose. The Pseudomonas genus (P.
It was recognized that it belongs to the genus seudomonas). Additionally, ■ requires cystine or methionine for growth, ■
Negative for arginine dihydrolase; ■Does not accumulate polybata hydroxybutyrate; ■Colonies are yellow; ■Does not produce xanthomonadin;
■ Pseudomonas maltophilia (Pseudomonas maltophilia)
tophilia).
以上の結果より、本発明者らは本菌株をシュードモナス
マルトフィリアの一菌株と同定し、これをシュードモ
ナス マルトフィリアLB−86(Pseudomon
as maltophllla LB−88)と命名し
た。Based on the above results, the present inventors identified this strain as a strain of Pseudomonas maltophilia, and it is known as Pseudomonas maltophilia LB-86 (Pseudomonas maltophilia).
As maltophlla LB-88).
該菌株は、通産省工業技術院微生物工業技術研究所に上
記表示にて、微工研菌寄第9813号(FERM P
−9813)として寄託された。The strain was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, with the above indication, and was approved by the Ministry of International Trade and Industry as a certified microorganism strain No. 9813 (FERM P).
-9813).
本発明のヌクレオシドオキシダーゼYT−1は、上記L
B−86株、その変異株等を含むシュードモナス、属に
属し、上記ヌクレオシドオキシダーゼYT−1の産生能
を有する微生物を培養することにより製造できる。The nucleoside oxidase YT-1 of the present invention comprises the above-mentioned L
It can be produced by culturing microorganisms that belong to the genus Pseudomonas, including the B-86 strain, its mutants, etc., and have the ability to produce the above-mentioned nucleoside oxidase YT-1.
上記微生物の培養は、適当な栄養含有培地中で実施でき
る。この培地としては、シュードモナス属に属する微生
物の培養に通常使用される各種の炭素源、窒素源、無機
物等を含有する合成培地、半合成培地及び天然培地のい
ずれをも使用することができる。上記炭素源としては具
体的には例えば高級脂肪酸、スターチ分解物(デキスト
リン)、マルトース、乳糖、ブドウ糖、糖密、果糖等の
微生物が同化可能な各種炭素化合物が単独で又は2種以
上組合せて用いられる。窒素源としては、例えばペプト
ン、肉エキス、酵母エキス、大豆粉、綿実粉、コンステ
ィープリカー等を例示できる。Cultivation of the above microorganisms can be carried out in a suitable nutrient-containing medium. As this medium, any synthetic medium, semi-synthetic medium, or natural medium containing various carbon sources, nitrogen sources, inorganic substances, etc. that are commonly used for culturing microorganisms belonging to the genus Pseudomonas can be used. Specifically, the above-mentioned carbon sources include various carbon compounds that can be assimilated by microorganisms, such as higher fatty acids, starch decomposition products (dextrin), maltose, lactose, glucose, molasses, and fructose, used alone or in combination of two or more. It will be done. Examples of the nitrogen source include peptone, meat extract, yeast extract, soybean flour, cottonseed flour, and corn steep liquor.
無機物としては、例えば食塩の他、カリウム、ナトリウ
ム、マグネシウム、カルシウム、亜鉛、鉄等の無機金属
のリン酸塩類や硫酸塩類等の無機塩類が必、要に応じて
適宜利用され得る。As the inorganic substance, for example, in addition to common salt, inorganic salts such as phosphates and sulfates of inorganic metals such as potassium, sodium, magnesium, calcium, zinc, and iron may be used as appropriate.
上記微生物の培養は、液体培養でも、固体培養でも実施
でき、通常通気攪拌条件下に、好気的に行なわれるのが
望ましい。培地のpH,培養温度、培養時間等の培養条
件は、培養する微生物の発育に適しており、しかも目的
とする酵素の生産金をできるだけ多くする条件から選択
されるのがよい。The above-mentioned microorganisms can be cultured by liquid culture or solid culture, and is preferably carried out aerobically under aeration and agitation conditions. Culture conditions such as pH of the medium, culture temperature, culture time, etc. are preferably selected from conditions that are suitable for the growth of the microorganism to be cultured and that produce as much of the desired enzyme as possible.
例えば培地のpHは約6〜8の範囲、培養温度は約20
〜35℃の範囲から選択されるのが好適である。培養時
間は目的とする酵素の生産蓄積量が最高に達する時間を
選べばよく、通常は約12〜48時間の範囲から選択さ
れる。勿論、上記培養の各条件や培養方法等は、用いる
微生物の種類や培養のための外的条件等に応じて適宜変
化させ得る。For example, the pH of the medium is in the range of about 6 to 8, and the culture temperature is about 20.
Preferably, the temperature is selected from the range of ~35°C. The culture time may be selected so that the production and accumulation of the desired enzyme reaches its maximum, and is usually selected from a range of about 12 to 48 hours. Of course, each culture condition, culture method, etc. described above can be changed as appropriate depending on the type of microorganism used, external conditions for culture, etc.
かくして得られる培養物中には、通常その菌体区分に、
目的とする酵素が蓄積される。この酵素の採取及びその
精製は、従来より微生物を利用して酵素2等を製造する
方法に採用されている通常の各種方法に従うことができ
る。上記精製手段としては、例えば溶媒に対する溶解性
を利用する手段、イオン結合力の差を利用する手段、分
子世の差を利用する手段、等電点の差を利用する手段、
疎水性の差を利用する手段等をそれぞれ単独で又は適宜
組合せて採用することができる。The culture thus obtained usually contains, in its cell division,
The target enzyme is accumulated. The collection and purification of this enzyme can be carried out in accordance with various conventional methods conventionally employed for producing enzyme 2 and the like using microorganisms. Examples of the above-mentioned purification means include means that utilize solubility in a solvent, means that utilizes a difference in ionic bonding force, means that utilizes a difference in molecular world, means that utilizes a difference in isoelectric point,
Means utilizing differences in hydrophobicity, etc. can be employed alone or in appropriate combinations.
上記菌体区分からの目的酵素の採取につき詳述すれば、
これは例えば遠心分離等の常法に従い集めて得られる湿
潤菌体を、リン酸緩衝液やトリス緩衝液等に懸濁させ、
超音波処理、フレンチプレス、リゾチーム処理等の種々
の菌体処理手段を適宜組合せ採用することにより行なわ
れ、がくして粗製酵素含有液を得ることができる。In detail, the collection of the target enzyme from the above bacterial cell divisions is as follows.
This involves suspending wet bacterial cells obtained by collecting them using a conventional method such as centrifugation in a phosphate buffer, Tris buffer, etc.
This can be carried out by appropriately combining various bacterial cell treatment methods such as ultrasonication, French press, and lysozyme treatment, and then a crude enzyme-containing liquid can be obtained.
上記粗製酵素含有液は、これを更に通常の方法により精
製して精製酵素標品を得ることができる。The above-mentioned crude enzyme-containing solution can be further purified by a conventional method to obtain a purified enzyme preparation.
この精製手段としては、例えばエタノール、アセトン等
の有機溶媒による分別沈澱法、硫安、硫酸アルミニウム
等を用いた塩析法等により、まず上記粗製酵素含有液か
ら沈澱を回収し、次いで該沈澱を、ジエチルアミノエチ
ルデキストラン等のイオン交換体、ポリアクリルアミド
ゲル等のゲル滑過剤によるクロマトグラフィー操作に付
すことにより実施でき、またかくして得られる精製酵素
標品は、更に凍結乾燥等の操作によって精製粉末標品と
することもできる。As a means for this purification, for example, a precipitate is first collected from the crude enzyme-containing solution by a fractional precipitation method using an organic solvent such as ethanol or acetone, or a salting-out method using ammonium sulfate, aluminum sulfate, etc., and then the precipitate is This can be carried out by subjecting it to chromatography using an ion exchanger such as diethylaminoethyl dextran or a gel slipping agent such as polyacrylamide gel, and the purified enzyme preparation thus obtained can be further purified into a purified powder preparation by freeze-drying or other operations. It is also possible to do this.
以上のようにして得られる本発明酵素は、前記した式(
1)及び(2)で示される酸化反応を触媒する酵素作用
を有する点において特徴づけられる他、以下に示す物理
化学的性質等を有する点においてもまた特徴付けられる
。The enzyme of the present invention obtained as described above has the above formula (
In addition to being characterized by having an enzymatic action that catalyzes the oxidation reactions shown in 1) and (2), it is also characterized by having the following physicochemical properties.
(1)基質特異性:
イノシン等の各種ヌクレオシドに作用する。ヒポキサン
チン等の塩基、イノシン酸等のヌクレオチド、リボース
等には作用しない。(1) Substrate specificity: Acts on various nucleosides such as inosine. It does not act on bases such as hypoxanthine, nucleotides such as inosinic acid, ribose, etc.
(2)温度及びpH安定性:
pH6,0,60℃、15分で95%以上残存し、70
℃、15分では失活する。(2) Temperature and pH stability: pH 6, 0, 95% or more remained in 15 minutes at 60°C, 70%
It is inactivated in 15 minutes at ℃.
また、37℃、60分の処理ではpH5,0〜6.0で
95%以上残存する。Further, when treated at 37° C. for 60 minutes, 95% or more remains at pH 5.0 to 6.0.
(3)至適pH: pH5,0〜6.0である。(3) Optimum pH: pH 5.0 to 6.0.
(4)分子量:約130000である。(4) Molecular weight: approximately 130,000.
(ゲル濾過法による) (5)等電点:pH5,3である。(by gel filtration method) (5) Isoelectric point: pH 5.3.
(6)阻害剤の影響ニジアン酸カリウム、アジ化ナトリ
ウムによって阻害される。(6) Effect of inhibitors Inhibited by potassium dianate and sodium azide.
(7)可視部吸収ニリン酸緩衝液等の中性緩衝液中にお
いては450nm以上に吸収極大がない。基質、亜ニチ
オン(ハイドロサルファイドナトリウム)等によって還
元されていない酸化型酵素は450nm以上に吸収極大
がない。(7) Visible absorption There is no absorption maximum at 450 nm or above in a neutral buffer such as diphosphate buffer. Oxidized enzymes that have not been reduced by the substrate, dinitzion (sodium hydrosulfide), etc., do not have an absorption maximum at 450 nm or more.
(8)金属含量:鉄を含む。(8) Metal content: Contains iron.
上記各物理化学的性質及びその他の性質については、後
記実施例において詳述する。The above-mentioned physicochemical properties and other properties will be described in detail in Examples below.
以上の性質を有する本発明酵素ヌクレオシドオキシダー
ゼYT−1は、従来のヌクレオシドオキシダーゼと同様
にヌクレオシドの定量に利用することができる。即ち、
本発明酵素はヌクレオシドを分子状酸素を電子受容体と
して酸化するので、酸素消費量の測定によりヌクレオシ
ドの定量に利用できる。この方法によれば、本発明酵素
の利用によりヌクレオシドを基質とする反応系やヌクレ
オシドを生成する反応系で該ヌクレオシドを測定でき、
これにより例えば5′−ヌクレオチダーゼ等のヌクレオ
シドを生成する反応を触媒する酵素等の各種酵素の活性
の測定等を行ない得る。また例えば魚介類の抽出液中の
ヌクレオシド量の測定により、該魚介類の鮮度の測定も
行なうことができ、更に例えばヌクレオシド−5′−カ
ルボン酸の製造等にも有用である。The enzyme nucleoside oxidase YT-1 of the present invention having the above properties can be used for quantitative determination of nucleosides in the same manner as conventional nucleoside oxidases. That is,
Since the enzyme of the present invention oxidizes nucleosides using molecular oxygen as an electron acceptor, it can be used to quantify nucleosides by measuring oxygen consumption. According to this method, by using the enzyme of the present invention, nucleosides can be measured in a reaction system that uses nucleosides as a substrate or a reaction system that produces nucleosides,
This makes it possible to measure the activity of various enzymes, such as enzymes that catalyze reactions that produce nucleosides, such as 5'-nucleotidase. Furthermore, for example, by measuring the amount of nucleosides in an extract of seafood, the freshness of the seafood can be determined, and it is also useful, for example, in the production of nucleoside-5'-carboxylic acid.
特に、本発明酵素は上記ヌクレオシドの酸化反応と同時
に、該ヌクレオシド存在下においてヌクレオシド量に応
じたラッカーゼ反応を示すという該酵素に特有の性質を
有している。しかもこのラッカーゼ様活性はヌクレオシ
ド量と完全に比例しており、従ってこの性質の利用によ
れば、例えばハイドロキノンのような代表的ラッカーゼ
基質を酸化させることができる他、ポリポラス・ベルシ
カラー(Polyporus versicolor)
起源のラッカーゼのように、4−アミノアンチピリンと
フェノールやアニリン系の物質等を酸化的にカップリン
グさせてキノンイミン等の色素を生成させることができ
、この色素生成量の測定によってヌクレオシド量を定量
することができる。更に本発明酵素の利用によれば、ヌ
クレオシドを遊離させる酵素反応の初速度を分光光学的
に正確且つ簡便に6(11定することができる。In particular, the enzyme of the present invention has a unique property of exhibiting a laccase reaction depending on the amount of nucleoside in the presence of the nucleoside simultaneously with the oxidation reaction of the nucleoside. Moreover, this laccase-like activity is completely proportional to the amount of nucleoside, and therefore, by utilizing this property, it is possible to oxidize typical laccase substrates such as hydroquinone, as well as Polyporus versicolor.
Like the original laccase, it can generate pigments such as quinoneimine by oxidatively coupling 4-aminoantipyrine with phenol or aniline-based substances, and the amount of nucleosides can be determined by measuring the amount of this pigment produced. be able to. Furthermore, by using the enzyme of the present invention, the initial rate of the enzymatic reaction that liberates nucleosides can be accurately and simply determined spectrophotometrically.
本発明は上記本発明酵素に特有のラッカーゼ活性を利用
した新しい被検液の検定方法をも提供するものである。The present invention also provides a new method for assaying a test liquid that utilizes the laccase activity specific to the enzyme of the present invention.
この検定方法につき、詳述すれば、該方法はヌクレオシ
ドを含有するか又はこれを生成させる系を被検液とし、
酸化により発色する発色試薬と上記被検液との混合物に
本発明のヌクレオシドオキシダーゼYT−1を作用させ
、被検液のヌクレオシド量変化に比例する上記発色試薬
の発色度合を測定することにより実施される。In detail, this assay method uses a system containing or producing nucleosides as a test solution,
It is carried out by applying the nucleoside oxidase YT-1 of the present invention to a mixture of a coloring reagent that develops color through oxidation and the above test liquid, and measuring the degree of color development of the above coloring reagent that is proportional to the change in the amount of nucleosides in the test liquid. Ru.
上記において用いられる被検液は、ヌクレオシドを含有
するか又はこれを遊離、生成させる系(ヌクレオシド生
成、遊離酵素反応系)であればいずれでもよい。上記被
検液の代表例としては以下の缶液を例示できる。The test solution used in the above may be any system as long as it contains nucleosides or is capable of releasing or producing nucleosides (nucleoside production, free enzyme reaction system). Representative examples of the test liquid include the following canned liquids.
(1) 5’−IMP、5’ −AMP等の5′−ヌ
クレオチドに5′−ヌクレオチダーゼを作用させてイノ
シン、アデノシン等のヌクレオシドを遊離させる酵素活
性測定用試料液
(2) 3’−IMP、3’ −AMP等の3′−ヌ
クレオチドに3′−ヌクレオチダーゼを作用させてイノ
シン、アデノシン等のヌクレオシドを遊離させる酵素活
性測定用試料液
(3) 生体成分の分解によってヌクレオシドを生じ
これを含む例えば鮮魚、獣肉等の鮮度測定用試料液
(4) RNA5DNA、オリゴヌクレオチド等にリ
ボヌクレアーゼやデオキシリボヌクレアーゼを作用させ
、生じるヌクレオチドに更にアルカリフォスファターゼ
等を作用させてヌクレオシドを遊離させるリボヌクレア
ーゼやデオキシリボヌクレアーゼの活性測定用試料液
(5) アデノシン、デオキシウリジン、キサントシ
ン、チミジン、ウリジン、グアノシン、シチジン、デオ
キシイノシン等のヌクレオシドの試薬試料液
(6) イノシナーゼ等のヌクレオシドを基質としこ
れを加水分解する酵素の活性測定用試料液。(1) Sample solution for measuring enzyme activity in which 5'-nucleotides such as 5'-IMP and 5'-AMP are exposed to 5'-nucleotidase to release nucleosides such as inosine and adenosine (2) 3'-IMP Sample solution for measuring enzyme activity (3) in which 3'-nucleotidase acts on 3'-nucleotides such as 3'-AMP to release nucleosides such as inosine and adenosine (3) Contains nucleosides produced by decomposition of biological components For example, a sample solution for measuring the freshness of fresh fish, meat, etc. (4) Activity measurement of ribonuclease or deoxyribonuclease in which ribonuclease or deoxyribonuclease is applied to RNA5DNA, oligonucleotides, etc., and alkaline phosphatase or the like is further applied to the resulting nucleotides to release nucleosides. (5) Reagent sample solution of nucleosides such as adenosine, deoxyuridine, xanthosine, thymidine, uridine, guanosine, cytidine, deoxyinosine, etc. (6) For measuring the activity of enzymes such as inosinase that use nucleosides as substrates and hydrolyze them. Sample liquid.
上記の内で特に、(1)に記載の酵素活性測定用試料液
、即ちヌクレオシド遊離酵素反応系としては、人血清と
ヌクレオチドとを含有する系を具体例として例示でき、
該系に対して本発明の検定法を実施する時には、上記人
血清中の5′−ヌクレオチダーゼ活性が測定され、これ
は肝機能検査法として非常に有用である。しかして、従
来上記人血清中の5′−ヌクレオチダーゼの活性測定法
としては、5’ −AMPを基質として遊離する無機リ
ンを測定する方法やアデノシンデアミナーゼ、グルタミ
ン酸デヒドロゲナーゼを利用した酵素法等が知られてい
るが、上記無機リンを測定する方法は、反応時間が長く
、操作が複雑であり、共存するアルカリフォスファター
ゼ活性の補正が必要である等の欠点があり、また上記酵
素法でも測定系が複雑であり、反応開始前に30分程度
の予備反応が必要である等の欠点があったが、本発明検
定法によれば非常に簡単な操作で、従来法より感度よく
、しかも通常約2〜5分秒度の非常に短時間で、目的と
する人血清中の5′−ヌクレオチダーゼ活性を測定する
ことができる。Among the above, the sample solution for enzyme activity measurement described in (1), that is, the nucleoside release enzyme reaction system, can be specifically exemplified by a system containing human serum and nucleotides.
When the assay method of the present invention is applied to this system, the 5'-nucleotidase activity in the human serum is measured, which is very useful as a liver function testing method. Conventionally, methods for measuring the activity of 5'-nucleotidase in human serum include methods that measure inorganic phosphorus released using 5'-AMP as a substrate, and enzymatic methods that utilize adenosine deaminase and glutamate dehydrogenase. However, the above methods for measuring inorganic phosphorus have drawbacks such as long reaction times, complicated operations, and the need to correct coexisting alkaline phosphatase activity.Also, even the enzymatic method described above has disadvantages in that the measurement system is However, the assay method of the present invention is very simple to operate, has higher sensitivity than conventional methods, and usually has a reaction time of about 20 minutes. The 5'-nucleotidase activity in target human serum can be measured in a very short time of ~5 minutes.
また、本発明検定法において用いられる酸化により発色
する発色試薬としては、単独の化合物で酸化されて可視
部に吸収を示す試薬及び2種以上の化合物の組合せで酸
化されて縮合して可視部に吸収を示す試薬が包含される
。上記単独化合物の例としては、各種のラッカーゼ基質
、例えば0−トリジン、o−トルイジン、0−ジアニシ
ジン、1O−N−メチルカルバモイル−3,7−シメチ
ルアミノー1O−H−フェノチアジン、ビス〔3−ビス
(4−クロロフェニル)−メチル−4−ジメチルアミノ
フェニル〕アミン等のアニリン系物質等を例示できる。In addition, the coloring reagents that develop color through oxidation used in the assay method of the present invention include reagents that are oxidized with a single compound and exhibit absorption in the visible region, and reagents that are oxidized with a combination of two or more compounds and condensed to produce an absorption in the visible region. Included are reagents that exhibit absorption. Examples of the above single compounds include various laccase substrates, such as 0-tolidine, o-toluidine, 0-dianisidine, 1O-N-methylcarbamoyl-3,7-dimethylamino-1O-H-phenothiazine, bis[3-bis( Examples include aniline-based substances such as 4-chlorophenyl)-methyl-4-dimethylaminophenyl]amine.
また、上記2種以上の化合物の組合せとしては、従来よ
り臨床診断薬として汎用されている4−アミノアンチピ
リン及びフェノールで代表されるように、所謂カップラ
ーとトリンダー試薬(水素供与体)との組合せを挙げる
ことができる。上記カップラーの具体例としては、4−
アミノアンチピリン(4−AA)の他、2゜6−ジブロ
モアミノフェノール、3−メチル−ベンゾチアゾリノン
ヒドラゾン等を、またトリンダー試薬(水素供与体)の
具体例としては、フェノールの他、β−クロロフェノー
ル、2,4−ジクロロフェノール、2,6−ジクロロフ
ェノール、N、N−ジメチルアニリン(DMA) 、N
−エチル−N−(2−ヒドロキシ−3−スルフオプロピ
ル)−m−アニンジン(ADO3) 、N−エチル−N
−(2−ヒドロキシ−3−スルフオプロピル)−アニリ
ン(ALO8) 、N−エチル−N−(2−ヒドロキシ
−3−スルフオプロビル)−m−トルイジン(TOO8
) 、N−エチル−N−スルフオプロピル) −m−ア
ニシジン(ADPS) 、N−エチル−N−スルフォプ
ロピルアニリン(ALPS) 、N−エチル−N−スル
フオンロピルー3,5−ジメトキシアニリン・ナトリウ
ム塩(DAPS) 、N−エチル−N−(2−ヒドロキ
シ−3−スルフォプロピル)−3,5−ジメトキシアニ
リン・ナトリウム塩(DAO3) 、N−スルフォプロ
ビルー3,5−ジメトキシアニリン(HDAPS) 、
N−(2−ヒドロキシ−3−スルフオンロピル)−3,
5−ジメトキシアニリン(HDAO8) 、N−エチル
−N−(2−ヒドロキシ−3−スルフオプロビル)−3
,5−ジメチルアニリン(MAO3) 、N−エチル−
N−スルフォプロピルー3,5−ジメチルアニリン(M
APS) 、N−エチル−N−スルフオプロビルーm−
トルイジン(TOPS) 、N2−エチル−N2− (
3−メチルフェニル)−N′−アセチルエチレンジアミ
ン(EMAE)等を例示できる。In addition, as a combination of two or more of the above-mentioned compounds, a combination of a so-called coupler and a Trinder reagent (hydrogen donor), as typified by 4-aminoantipyrine and phenol, which have been widely used as clinical diagnostic agents, may be used. can be mentioned. Specific examples of the above couplers include 4-
In addition to aminoantipyrine (4-AA), 2゜6-dibromoaminophenol, 3-methyl-benzothiazolinone hydrazone, etc., and as specific examples of Trinder reagent (hydrogen donor), in addition to phenol, β- Chlorophenol, 2,4-dichlorophenol, 2,6-dichlorophenol, N,N-dimethylaniline (DMA), N
-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-aningine (ADO3), N-ethyl-N
-(2-hydroxy-3-sulfopropyl)-aniline (ALO8), N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine (TOO8)
), N-ethyl-N-sulfopropyl)-m-anisidine (ADPS), N-ethyl-N-sulfopropylaniline (ALPS), N-ethyl-N-sulfopropyl-3,5-dimethoxyaniline・Sodium salt (DAPS), N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline sodium salt (DAO3), N-sulfoprobyl-3,5-dimethoxyaniline ( HDAPS),
N-(2-hydroxy-3-sulfonropyl)-3,
5-dimethoxyaniline (HDAO8), N-ethyl-N-(2-hydroxy-3-sulfoprovir)-3
, 5-dimethylaniline (MAO3), N-ethyl-
N-sulfopropyl-3,5-dimethylaniline (M
APS), N-ethyl-N-sulfoprobyl-m-
Toluidine (TOPS), N2-ethyl-N2- (
Examples include 3-methylphenyl)-N'-acetylethylenediamine (EMAE).
本発明検定法によれば、まず上記被検液と発色試薬との
混合物に本発明酵素を作用させる。これは通常被検液に
発色試薬を添加し、更に本発明酵素を添加するか又は発
色試薬に本発明酵素を添加した液に、被検液を添加し、
その後混合物を所定温度下に所定時間放置することによ
り実施され、かくして酵素反応によって、発色試薬の発
色が認められる。上記において、被検液は適当に希釈し
て利用できる。ここで用いられる希釈液としては例えば
リン酸緩衝液、トリス塩酸緩衝液等の各種の緩衝液や水
等を例示できる。また、上記酵素反応系における各試薬
の使用量は、任意に決定され特に限定されるものではな
いが、通常発色試薬は反応系における濃度が約0.1〜
10tr+M程度の範囲となる量で、本発明酵素は反応
液1或当たり約0.05〜10ユニツトの範囲で、また
被検液は該液中のヌクレオシド濃度が反応液において約
0〜0.2mM以下の濃度の範囲となる量でそれぞれ用
いられるのが好適である。また酵素反応系の反応条件は
、特に制限されるものではないが、通常約20〜40℃
の温度条件を採用するのがよく、反応時間は使用する本
発明酵素の量、反応温度、pH等に応じて適宜決定でき
、一般には非常に短く、約20分以内で反応は完結する
。更に上記酵素反応系のpHは通常約3〜10の範囲内
であれば充分に良好に反応は進行するが、一般にはpH
約4〜8の範囲とするのが好適である。According to the assay method of the present invention, first, the enzyme of the present invention is allowed to act on a mixture of the above-mentioned test liquid and a coloring reagent. This is usually done by adding a coloring reagent to a test solution and then adding the enzyme of the present invention, or adding the test solution to a solution in which the enzyme of the present invention is added to a coloring reagent.
This is then carried out by leaving the mixture at a predetermined temperature for a predetermined period of time, and color development of the coloring reagent is observed due to the enzymatic reaction. In the above, the test liquid can be appropriately diluted and used. Examples of the diluent used here include various buffer solutions such as phosphate buffer and Tris-HCl buffer, water, and the like. Further, the amount of each reagent used in the enzyme reaction system is arbitrarily determined and is not particularly limited, but the concentration of coloring reagents in the reaction system is usually about 0.1 to 1.
The amount of the enzyme of the present invention is approximately 0.05 to 10 units per reaction solution, and the nucleoside concentration of the test solution is approximately 0 to 0.2 mM in the reaction solution. It is preferable to use each in an amount within the following concentration range. In addition, the reaction conditions of the enzyme reaction system are not particularly limited, but are usually about 20 to 40°C.
The reaction time can be appropriately determined depending on the amount of the enzyme of the present invention used, the reaction temperature, pH, etc., and is generally very short, and the reaction is completed within about 20 minutes. Furthermore, if the pH of the enzyme reaction system is within the range of approximately 3 to 10, the reaction will proceed satisfactorily;
A range of approximately 4 to 8 is preferred.
本発明方法では次いで上記酵素反応混合液の発色度合を
測定することによって被検液のヌクレオシド量変化を測
定することができる。この発色度合の測定は、通常の方
法に従って、酵素反応により生じる色素等の可視部に吸
収を示す物質の該可視部吸収を分光学的に測定すること
により行ない得る。例えば4−アミノアンチピリンとフ
ェノールとからキノンイミン色素を生成する系では分光
光度計を用いて、500 nmの吸光度を測定すること
により、その発色度合を測定できる。その他の系の代表
例及び之等各系における吸光度測定の実例は後記実施例
において詳述する。In the method of the present invention, the change in the amount of nucleosides in the test solution can then be measured by measuring the degree of color development of the enzyme reaction mixture. The degree of color development can be measured by spectroscopically measuring the absorption in the visible region of a substance that exhibits absorption in the visible region, such as a dye produced by an enzyme reaction, according to a conventional method. For example, in a system that produces a quinoneimine dye from 4-aminoantipyrine and phenol, the degree of color development can be measured by measuring the absorbance at 500 nm using a spectrophotometer. Representative examples of other systems and actual examples of absorbance measurement in each system will be described in detail in Examples below.
更に本発明の上記分析法において、被検液としてヌクレ
オシドを遊離させる酵素反応系、例えばヌクレオチダー
ゼ等を含有する液を用いる場合は、上記本発明酵素によ
る反応を分光光度計のセル中で行ない、単位時間当たり
の吸光度の増加を求めることによって、上記ヌクレオチ
ダーゼ等の酵素活性を測定することもできる。Furthermore, in the above analysis method of the present invention, when an enzyme reaction system that liberates nucleosides, such as a solution containing a nucleotidase, is used as the test solution, the reaction using the enzyme of the present invention is carried out in a cell of a spectrophotometer, Enzyme activity such as the above-mentioned nucleotidase can also be measured by determining the increase in absorbance per unit time.
以上の通り、本発明によれば本発明酵素を利用してなる
、ヌクレオシドの定量やヌクレオシドを生成、遊離する
系等における各種酵素の活性測定に極めて有効な新しい
分析法が提供される。As described above, the present invention provides a new analytical method that utilizes the enzyme of the present invention and is extremely effective for quantifying nucleosides and measuring the activity of various enzymes in systems that generate and release nucleosides.
実 施 例
以下、本発明を更に詳しく説明するため実施例を挙げる
。EXAMPLES Examples will be given below to explain the present invention in more detail.
尚、ヌクレオシドオキシダーゼ活性は、以下の方法によ
り測定した。In addition, nucleoside oxidase activity was measured by the following method.
〈ヌクレオシドオキシダーゼ活性測定法〉7mMイノシ
ンを含む100mMリン酸緩衝液(pH6,0)1m1
2を酵素電極のセルに入れ、酵素標品5μQを添加し、
25℃において酵素消費の初速度を測定する。即ち、2
5℃における飽和溶存酸素量的250μMからの溶存酸
素量の減少を酸素電極により経時的に測定し、1分間当
たり1μモルの酸素を消費させた場合を1ユニツト(U
)とする。<Nucleoside oxidase activity measurement method> 1ml of 100mM phosphate buffer (pH 6.0) containing 7mM inosine
2 into the cell of the enzyme electrode, add 5μQ of the enzyme preparation,
The initial rate of enzyme consumption is determined at 25°C. That is, 2
The decrease in the amount of dissolved oxygen from 250 μM in terms of saturated dissolved oxygen at 5°C is measured over time using an oxygen electrode, and the consumption of 1 μmol of oxygen per minute is 1 unit (U).
).
実施例 1
シュードモナス マルトフィリアLB−86(Pseu
domonas maltophilla LB−86
、微工研菌寄第9813号)を、ブイヨン培地(肉エキ
ス1%、ペプトン1%及びNaCQO,5%、以下同じ
)100脱を500鵬容の坂ロフラスコに入れたものに
接種し、25℃で12時間振盪培養(110rpm)し
て種培養物を得る。Example 1 Pseudomonas maltophilia LB-86 (Pseu
domonas maltophila LB-86
, Kaikoken Bacteria Serial No. 9813) was inoculated into a 500-capacity Sakalo flask containing 100 drops of bouillon medium (1% meat extract, 1% peptone, and 5% NaCQO, the same hereinafter). A seed culture is obtained by culturing with shaking (110 rpm) at ℃ for 12 hours.
得られた種培養物を、予め10f2容量のジャーファー
メンタ−に殺菌した6Qのブイヨン培地及び消泡剤「ア
デカノール」 (旭電化工業社製)0.07%を添加し
たものの中に接種(接種n:2%)する。培養温度25
℃、攪拌25Orpm。The obtained seed culture was inoculated (inoculated) into a 6Q bouillon medium that had been previously sterilized in a jar fermenter with a capacity of 10 f2 and 0.07% of the antifoam agent "Adekanol" (manufactured by Asahi Denka Kogyo Co., Ltd.) was added. n: 2%). Culture temperature 25
°C, stirring 25 rpm.
通気m6Q/分の条件で12時間培養し、培養終了後、
集菌し、IQのリン酸緩衝液(pH6,0)に菌体を懸
濁させ、20KHz、200Wの条件で15分間超音波
処理を行なう。かくして菌体抽出液を得る。Cultured for 12 hours under aeration conditions of m6Q/min, and after completion of culture,
The bacteria were collected, suspended in IQ phosphate buffer (pH 6,0), and subjected to ultrasonication at 20 KHz and 200 W for 15 minutes. In this way, a bacterial cell extract is obtained.
このもののヌクレオシドオキシダーゼ活性は、1.2U
/戒であった。The nucleoside oxidase activity of this product is 1.2U
/ It was a precept.
実施例 2
シュードモナス マルトフィリアLB−86(微工研菌
寄第9813号)を、ブイヨン培地100或を500或
容の坂ロフラスコに入れたものに接種し、25℃で12
時間振盪培養(110rpm)して種培養物を得る。Example 2 Pseudomonas maltophilia LB-86 (Feikoken Bacteria No. 9813) was inoculated into a Sakalo flask containing 100 or 500 volumes of broth medium, and incubated at 25°C for 12 hours.
A seed culture is obtained by shaking culture (110 rpm) for hours.
得られた種培養物を、予め500TIIQ容量の坂ロフ
ラスコに殺菌した100或の酵母エキス・グルコース培
地(酵母エキス2.5%、グルコース3%、KCQo、
1%、KH2PO40,1%、MgSO4・7H200
,05%、pH7,2)を入れたものの中に接種(接種
量:2%)する。The obtained seed culture was placed in a pre-sterilized 100% yeast extract/glucose medium (yeast extract 2.5%, glucose 3%, KCQo,
1%, KH2PO40, 1%, MgSO4・7H200
, 05%, pH 7.2) (inoculation amount: 2%).
培養温度25℃、攪拌110rpmの条件で24時間培
養し、培養終了後、集菌し、フラスコ1本当たり30戒
のリン酸緩衝液(p H7,0)に菌体を懸濁させ、以
後実施例1と同条件下に超音波処理を行なう。かくして
菌体抽出液を得る。Culture was carried out for 24 hours at a culture temperature of 25°C and stirring at 110 rpm. After the culture was completed, the bacteria were collected, and the cells were suspended in a phosphate buffer solution (pH 7,0) at a concentration of 30 per flask. Ultrasonication is carried out under the same conditions as in Example 1. In this way, a bacterial cell extract is obtained.
このもののヌクレオシドオキシダーゼ活性は、7、OU
/戒であった。The nucleoside oxidase activity of this product is 7, OU
/ It was a precept.
実施例 3
実施例2と同様にして得られた菌体抽出液272Ttl
Qに、20%ストレプトマイシン硫酸塩60脱を添加し
て生じた沈澱を遠心除去した後、硫安を35%飽和にな
るように添加する。生じた沈澱を除去した後、更に硫安
を60%飽和になるまで添加する。冷所に一夜放置して
沈澱を生成させた後、これを集め、20mMリン酸緩衝
液(pH6,0)に溶解させる。これを透析チューブに
人、れ、−日透析した後、予め20mMリン酸緩衝液(
pH6,0)で平衡化したDEAE−トヨバール650
Mカラム(トーソー社製)にかけ、同緩衝液で充分洗浄
後、食塩0〜0.5Mのリニアグラジェントにて溶出さ
せる。Example 3 272Ttl of bacterial cell extract obtained in the same manner as in Example 2
After adding 20% streptomycin sulfate 60% to Q and removing the resulting precipitate by centrifugation, ammonium sulfate is added to give 35% saturation. After removing the formed precipitate, ammonium sulfate is further added to 60% saturation. After leaving in a cold place overnight to form a precipitate, the precipitate is collected and dissolved in 20 mM phosphate buffer (pH 6,0). This was placed in a dialysis tube and dialyzed for - days, then preliminarily prepared with 20mM phosphate buffer (
DEAE-Toyovar 650 equilibrated at pH 6,0)
The column was applied to an M column (manufactured by Toso Corporation), washed thoroughly with the same buffer, and then eluted with a linear gradient of 0 to 0.5M sodium chloride.
活性画分を分画分子ff120000のアミコン膜(ア
ミコン社製)を用いて濃縮し、更に20mMリン酸緩衝
液(pH6,0)で平衡化したセファクリールS−20
0カラム(ファルマシア社製)にチャージしてゲル濾過
を行なう。溶出してくる活性画分を集め、再び分画分子
ff120000のアミコン膜で濃縮し、セファクリー
ルS−200によるゲル濾過を繰返す。The active fraction was concentrated using an Amicon membrane (manufactured by Amicon) with a fractionation molecule ff120000, and was further equilibrated with 20 mM phosphate buffer (pH 6,0) using Sephacryl S-20.
0 column (manufactured by Pharmacia) and perform gel filtration. The eluted active fractions are collected, concentrated again using an Amicon membrane with fractionation molecules ff120000, and gel filtration using Sephacryl S-200 is repeated.
上記で溶出してくる活性画分を集め、凍結乾燥を行なう
ことにより、精製ヌクレオンドオキシダーゼYT−1を
得る。The active fractions eluted above are collected and freeze-dried to obtain purified nucleondooxidase YT-1.
この精製品は、ディスク電気泳動的に単一であった。This purified product was disk electrophoretically single.
上記1、精製結果をまとめて下記第1表に示す。The results of the above 1 and purification are summarized in Table 1 below.
第1表
以下、上記実施例3で得られた本発明ヌクレオシドオキ
シダーゼYT−1精製標品の性質の試験例につき詳述す
る。Below in Table 1, a test example of the properties of the purified nucleoside oxidase YT-1 sample of the present invention obtained in Example 3 will be described in detail.
(1)酵素作用試験I
■ 酸化反応生成物の検出
酵素、標品10Uを、適当量の水に溶解させて透析チュ
ーブに入れ、7mMイノシン溶液100mQ中に投入し
て反応させた。(1) Enzyme action test I ■ Detection of oxidation reaction products 10 U of the standard enzyme was dissolved in an appropriate amount of water, placed in a dialysis tube, and placed in 100 mQ of 7 mM inosine solution for reaction.
反応0分〜800分の間の適当時間にそれぞれ反応液の
一部を採取し、高速液体クロマトグラフィー(HPLC
)にて分析した。該HPLCはファインSIL018(
F1neSILcm8、日本分光社製)カラムを用い、
溶媒として50mMリン酸緩衝液(pH3,0)/メタ
ノール=9515を使用し、流速1. 5mQ/分とし
て、260 nmの吸光度検出を行なった。A portion of the reaction solution was collected at appropriate times between 0 minutes and 800 minutes of reaction, and subjected to high performance liquid chromatography (HPLC).
) was analyzed. The HPLC is fine SIL018 (
Using a F1neSILcm8 (manufactured by JASCO Corporation) column,
50mM phosphate buffer (pH 3,0)/methanol=9515 was used as the solvent, and the flow rate was 1. Absorbance detection was performed at 260 nm at 5 mQ/min.
所定時間での結果を第1図に示す。The results at a given time are shown in FIG.
図においてX軸はリテンションタイム(分)を、y軸は
反応時間(インキュベーションタイム、分)を、Z軸は
260nmでの吸光度を示す。In the figure, the X axis shows retention time (minutes), the y axis shows reaction time (incubation time, minutes), and the Z axis shows absorbance at 260 nm.
第1図より次のことが判る。即ち、経時的にイノシンは
減少し、これに伴って2つのピーク(P−1及びP−2
)が現われ、p−1は反応の初期に増加後、次第に減少
しやがて消失し、最終的にはP−2のみが残存した。The following can be seen from Figure 1. That is, inosine decreases over time, resulting in two peaks (P-1 and P-2).
) appeared, and p-1 increased at the beginning of the reaction, then gradually decreased and disappeared, and finally only P-2 remained.
上記P−1をHPLCにより分離してヌクレオシドオキ
シダーゼ酵素標品と反応させた所、酸素の消費を伴って
P−2に変化することが確認された。一方、P−2は上
記酵素標品との反応に供しても変化はなかった。When the above P-1 was separated by HPLC and reacted with a nucleoside oxidase enzyme preparation, it was confirmed that it changed to P-2 with the consumption of oxygen. On the other hand, P-2 did not change even when subjected to the reaction with the above enzyme preparation.
この結果より本発明酵素標品はイノシンを酸化してP−
1を生成し、更に該P−1を酸化してP−2を生成する
作用を有することが判った。From this result, the enzyme preparation of the present invention oxidizes inosine and P-
It was found that it has the effect of producing P-1 and further oxidizing P-1 to produce P-2.
■ 反応生成物の同定
■−I P−1及びP−2の調製
イノシン水溶液(2mg/mQ) 100n12に透析
チューブに入れた本酵素標品100Uを投入し、通気攪
拌しなから37°Cで一夜反応させ、p−2を生成させ
た。透析チューブを取出した後、反応液に塩酸を添加し
てpH3,0とし、生じたp−2の結晶を遠心分離によ
り集めた。これをpH3,0の塩酸溶液で洗浄し、減圧
乾燥させてP−2の結晶的190Bを得た。■Identification of reaction products■-I Preparation of P-1 and P-2 Add 100U of this enzyme preparation in a dialysis tube to an inosine aqueous solution (2mg/mQ) 100N12, and heat at 37°C without aeration and stirring. The reaction was allowed to proceed overnight to produce p-2. After removing the dialysis tube, hydrochloric acid was added to the reaction solution to adjust the pH to 3.0, and the resulting p-2 crystals were collected by centrifugation. This was washed with a hydrochloric acid solution of pH 3.0 and dried under reduced pressure to obtain crystalline 190B of P-2.
また本酵素標品10Uを透析チューブに入れ、上記P−
2の調製と同様にしてイノシン水溶液に投入して反応さ
せた。経時的に反応物を採取し、HPLCにて分析し、
P−1蓄積量が増加した時点(37℃、約30分)で、
酵素を入れた透析チューブを取出し、反応を停止させた
。この反応液を減圧濃縮後、HPLCにてp−1画分を
分離し、凍結乾燥により精製して、P−1粉末を得た。In addition, put 10 U of this enzyme preparation into a dialysis tube, and
In the same manner as in the preparation of 2, it was added to an aqueous inosine solution and reacted. The reaction product was collected over time and analyzed by HPLC,
At the time when the amount of P-1 accumulated increased (37°C, about 30 minutes),
The dialysis tube containing the enzyme was removed to stop the reaction. After concentrating this reaction solution under reduced pressure, the p-1 fraction was separated by HPLC and purified by freeze-drying to obtain P-1 powder.
■−2P−1及びP−2の塩基成分及び糖の分析P−1
、P−2及びイノシンをそれぞれIN塩酸にて100℃
、1時間加水分解した。それぞれの分解液について、含
有される塩基及び糖の分析を行なった。■-2 Analysis of base components and sugars of P-1 and P-2 P-1
, P-2 and inosine in IN hydrochloric acid at 100°C.
, hydrolyzed for 1 hour. The bases and sugars contained in each decomposition solution were analyzed.
その結果、いずれの塩基成分も、薄層クロマトグラフィ
ー及びHPLCにおいて、ヒポキサンチンの標準品と同
一挙動を示した。このことから上記P−1及びP−2の
塩基成分は、共にイノシンと同じヒポキサンチンである
と同定できた。As a result, all base components exhibited the same behavior as the standard hypoxanthine product in thin layer chromatography and HPLC. From this, the base components of P-1 and P-2 were both identified as hypoxanthine, which is the same as inosine.
また上記薄層クロマトグラフィーにおける糖の分析では
、イノシンの分解液からはD−リボースが検出されたが
、P−1及びP−2の分解液からはD−リボースとは異
なる位置にスポットが検出された。このことから、P−
1及びP−2ではイノシンの糖部分が酸化されているこ
とが明らかとなった。In addition, in the sugar analysis by thin layer chromatography mentioned above, D-ribose was detected from the inosine decomposition solution, but a spot was detected at a different position from D-ribose from the P-1 and P-2 decomposition solutions. It was done. From this, P-
It became clear that the sugar moiety of inosine in 1 and P-2 was oxidized.
■−3P−1の同定
P−1を1.2倍当量の水素化硼素ナトリウムにより還
元した。この還元生成物を薄層クロマトグラフィー及び
HPLCで分析した所、その挙動はイノシンの標準品と
一致した。従って、p−1の水素化硼素ナトリウムによ
る還元生成物はイノシンであると同定された。しかして
、水素化硼素ナトリウムにより還元され、基質であるイ
ノシンに戻り得る唯一の構造はイノシン−5′−アルデ
ヒドのみである。これはP−1の核磁気共鳴スペクトル
及び赤外線スペクトルによっても支持された。以上より
P−1をイノシン−5′−アルデヒドと同定した。(1)-3Identification of P-1 P-1 was reduced with 1.2 equivalents of sodium borohydride. When this reduced product was analyzed by thin layer chromatography and HPLC, its behavior was consistent with that of a standard product of inosine. Therefore, the reduction product of p-1 with sodium borohydride was identified as inosine. Therefore, inosine-5'-aldehyde is the only structure that can be reduced by sodium borohydride and returned to the substrate inosine. This was also supported by the nuclear magnetic resonance and infrared spectra of P-1. From the above, P-1 was identified as inosine-5'-aldehyde.
■−4P−2の同定
P−2の結晶標品のC1C13−Nスペクトル及びHl
−NMRスペクトルを測定した。■-4Identification of P-2 C1C13-N spectrum and Hl of crystal specimen of P-2
-NMR spectra were measured.
C1C13−Nは完全カップリング及びデカップリング
にて、Hl −NMRはジメチルスルフオキシド(DM
SO−ds)中のスペクトル及びその重水(D20)添
加後のスペクトル測定にて行なった。C1C13-N is completely coupled and decoupled, Hl-NMR is dimethyl sulfoxide (DM
This was done by measuring the spectrum in SO-ds) and the spectrum after adding heavy water (D20).
その結果、全てのシグナルは、そのケミカルシフト、結
合定数等によって、下記第2表のように帰属でき、この
ことがらp−2はイノシン−5′−カルボン酸と同定で
きた。As a result, all signals could be assigned as shown in Table 2 below based on their chemical shifts, binding constants, etc., and p-2 could be identified as inosine-5'-carboxylic acid.
第 2 表
H
HOH
但し、表中Sはシングレットを、dはダブレットを示す
。Table 2 H HOH However, in the table, S indicates a singlet and d indicates a doublet.
■ 反応の化学量論
50ナノモルのイノシンを含む100mMリン酸緩衝液
1脱に本酵素標品IUを添加し、酸素消費量、P−2生
成量及び過酸化水素量を測定した。(2) Reaction stoichiometry IU of this enzyme preparation was added to 100 mM phosphate buffer containing 50 nmoles of inosine, and the amount of oxygen consumed, amount of P-2 produced, and amount of hydrogen peroxide were measured.
その結果、イノシン50ナノモルにおける酸素消費量5
1ナノモルにおいてP−2の47ナノモルを生成した。As a result, the oxygen consumption for 50 nmoles of inosine was 5
47 nmoles of P-2 were produced in 1 nmole.
また過酸化水素は検出されなかった。Furthermore, no hydrogen peroxide was detected.
次に、100ナノモルのPlを含む100mMリン酸緩
衝液1脱に本酵素標品IUを添加し、酸素消費ffl、
P−2生成0及び過酸化水素量を測定した。Next, IU of this enzyme preparation was added to 100 mM phosphate buffer containing 100 nmoles of Pl, and oxygen consumption ffl,
P-2 production 0 and hydrogen peroxide amount were measured.
その結果、P−1の100ナノモルにおける酸素消費量
48ナノモルにおいてP−2の97ナノモルを生成した
。この場合も過酸化水素は検出されなかった。As a result, 97 nmoles of P-2 were produced at an oxygen consumption of 48 nmoles in 100 nmoles P-1. In this case too, no hydrogen peroxide was detected.
また、上記反応において、カタラーゼIUを添加した場
合においても、酸素消費量に差が認められず、この点か
らも本反応においては過酸化水素は発生しないことが明
らかにされた。Further, in the above reaction, no difference was observed in the amount of oxygen consumed even when IU of catalase was added, and from this point as well, it was revealed that hydrogen peroxide was not generated in this reaction.
以上の結果より、本発明酵素は、イノシン1モルを1.
72モルの酸素を電子受容体として酸化して、1モルの
イノシン−5′−アルデヒドと1モルの水とを生成し、
更に1モルのイノシン−5′アルデヒドを1/2モルの
酸素を電子受容体として酸化して、1モルのイノシン−
5′−カルボン酸を生成することが明らかとなった。From the above results, the enzyme of the present invention shows that 1 mole of inosine is 1 mole of inosine.
Oxidize 72 moles of oxygen as an electron acceptor to produce 1 mole of inosine-5'-aldehyde and 1 mole of water;
Furthermore, 1 mole of inosine-5' aldehyde is oxidized using 1/2 mole of oxygen as an electron acceptor to form 1 mole of inosine-5'aldehyde.
It was revealed that 5'-carboxylic acid was produced.
(2)酵素作用試験■
■ 1,4−ハイドロキノンを基質とした時の反応生成
物の同定と化学量論
0.5μモルのイノシン及び0,2μモルの1゜4−ハ
イドロキノンを含む100mMリン酸緩衝液(pH7,
0)1脱に本酵素標品IUを加え、室温で10分間反応
させ、反応生成物をHPLCにより分析した。(2) Enzyme action test ■ Identification of reaction products when 1,4-hydroquinone is used as a substrate and stoichiometry of 100 mM phosphoric acid containing 0.5 μmol of inosine and 0.2 μmol of 1°4-hydroquinone Buffer solution (pH 7,
IU of this enzyme preparation was added to 0)1 reaction, reacted for 10 minutes at room temperature, and the reaction product was analyzed by HPLC.
その結果、溶出位置はp−キノンの標準品のそれと一致
した。As a result, the elution position coincided with that of the p-quinone standard product.
更にその紫外線スペクトルも一致した。Furthermore, their ultraviolet spectra also matched.
従って、上記反応生成物はp−キノンと同定された。Therefore, the reaction product was identified as p-quinone.
また、0.06μモルのイノシン及び0.12μモルの
1,4−ハイドロキノンを含む100mMリン酸緩衝液
(pH7,0) 1+1112に本酵素標品IUを加え
、室温で10分間反応させ、この時の酸素消費量を酸素
電極を用いて測定した。In addition, IU of this enzyme preparation was added to 100 mM phosphate buffer (pH 7.0) 1+1112 containing 0.06 μmol of inosine and 0.12 μmol of 1,4-hydroquinone, and reacted for 10 minutes at room temperature. The oxygen consumption was measured using an oxygen electrode.
その結果、酸素消費量は0.115μモルであり、この
うちイノシンの酸化に用いられた酸素0.06μモルを
差引いた値0.055μモルは、0.12μモルの1,
4−ハイドロキノンの酸化に用いられたことになる。As a result, the oxygen consumption was 0.115 μmol, of which 0.055 μmol was obtained by subtracting 0.06 μmol of oxygen used for the oxidation of inosine, which was 0.12 μmol of 1,
This means that it was used for the oxidation of 4-hydroquinone.
従って、本酵素は、1モルの1,4−ハイドロキノンを
1/2モルの酸素で酸化して、1モルのp−キノンと1
モルの水とを生成すると認められた。これは即ち、従来
知られているラッカーゼ(Laccase EC1,l
OJ、2 )の反応に合致する。Therefore, this enzyme oxidizes 1 mole of 1,4-hydroquinone with 1/2 mole of oxygen to produce 1 mole of p-quinone and 1 mole of p-quinone.
It was found to produce mol of water. This means that the conventionally known laccase (Laccase EC1, l)
This conforms to the reaction of OJ, 2).
■ ヌクレオシド酸化とラッカーゼ作用の関連本酵素と
1,4−ハイドロキノン等のラッカーゼ基質を混合して
も何らの反応も起こらない。しかるに、上記反応系にイ
ノシン、アデノシン等のヌクレオシドを共存させるとラ
ッカーゼ反応が起こる。即ち、本酵素のラッカーゼ活性
はヌクレオシドの存在を必須とするものであり、この事
実は、以下の試験により確認された。(2) Relationship between nucleoside oxidation and laccase action No reaction occurs when this enzyme is mixed with a laccase substrate such as 1,4-hydroquinone. However, when nucleosides such as inosine and adenosine are coexisting in the above reaction system, a laccase reaction occurs. That is, the laccase activity of this enzyme requires the presence of nucleosides, and this fact was confirmed by the following test.
0.06μモルのイノシン及び0.02.0.06.0
.12及び0.6μモルのいずれかの1,4−ハイドロ
キノンを含む100mMリン酸緩衝液(pH7,0)1
+nQに、本酵素IUを作用させた。この時の酸素消費
量及びp−キノンの生成丘を調べた結果を下記第3表に
示す。0.06 μmol inosine and 0.02.0.06.0
.. 100 mM phosphate buffer (pH 7,0) containing either 12 or 0.6 μmol of 1,4-hydroquinone
+nQ was treated with IU of this enzyme. The results of examining the oxygen consumption and p-quinone production at this time are shown in Table 3 below.
第3表
上記第3表より、本酵素は1モルのヌクレオシドを、1
モルの酸素を電子受容体として酸化させる場合、同時に
且つ該ヌクレオシドの酸化とは別に、酸素1モルを電子
受容体としてラッカーゼ反応を行なうことが確認される
。Table 3 From Table 3 above, this enzyme converts 1 mole of nucleoside into 1
It is confirmed that when a mole of oxygen is oxidized as an electron acceptor, simultaneously and separately from the oxidation of the nucleoside, a laccase reaction is carried out using 1 mole of oxygen as an electron acceptor.
■ フェノール、4−アミノアンチピリンに対する作用
本酵素は、ヌクレオシド存在下に、従来知られているラ
ッカーゼ(ポリポラス ペルシカラー起源等)と同様に
、フェノールと4−アミノアンチピリンとを酸化的にカ
ップリング反応させて、赤色のキノンイミン色素を生成
させる。この時生成される赤色色素は、その紫外、可視
吸収スペクトル及びHPLCによる溶出位置等において
、従来の過酸化水素存在下におけるパーオキシダーゼに
よる上記フェノール−4−アミノアンチピリンの酸化反
応により生成するキノンイミン色素と同一であることが
確認される。■ Effect on phenol and 4-aminoantipyrine This enzyme causes an oxidative coupling reaction between phenol and 4-aminoantipyrine in the presence of nucleosides, similar to conventionally known laccases (derived from Polyporus persicolor, etc.). to produce a red quinoneimine dye. The red pigment produced at this time is different from the quinone imine pigment produced by the conventional oxidation reaction of phenol-4-aminoantipyrine with peroxidase in the presence of hydrogen peroxide in its ultraviolet and visible absorption spectra and elution position by HPLC. It is confirmed that they are the same.
上記本発明酵素によるキノンイミン色素の生成(発色度
合)とヌクレオシド量との関係を以下の通り調べた。即
ち、ヌクレオシドとしてイノシンを用い、これを10m
Mフェノール及び4−アミノアンチピリンを含む100
mMリン酸緩衝液(pH7,0) BrrIQ中に所定
濃度で添加し、該液中にIUの本酵素を添加して反応、
発色を行なわせた。その結果は第2図に示す通りである
。The relationship between the production of quinoneimine dye (degree of color development) by the enzyme of the present invention and the amount of nucleoside was investigated as follows. That is, inosine was used as the nucleoside, and 10 m
100 containing M phenol and 4-aminoantipyrine
Add a prescribed concentration of mM phosphate buffer (pH 7,0) to BrrIQ, add IU of this enzyme to the solution, and react.
Color development was performed. The results are shown in FIG.
図において、横軸はイノシン濃度(ナノモル)を、縦軸
は500nmでの吸光度を示す。In the figure, the horizontal axis shows the inosine concentration (nanomole), and the vertical axis shows the absorbance at 500 nm.
第2図より、ヌクレオシド合と発色との間には直線関係
が成立しており、このことがら本酵素は上記反応を利用
してヌクレオシドの比色字母に利用できることが明らか
である。From FIG. 2, a linear relationship is established between nucleoside synthesis and color development, and it is clear from this that the present enzyme can be used in colorimetric dials of nucleosides by utilizing the above reaction.
(3)基質特異性試験
下記、第4表に示す各種の化合物を基質として、これら
に対する本酵素の相対活性(イノシンに対する活性を1
00とする)を測定した。(3) Substrate specificity test Using the various compounds shown in Table 4 below as substrates, the relative activity of this enzyme against these (the activity against inosine is 1
00) was measured.
結果を第4表に併記する。The results are also listed in Table 4.
第4表 前後の試料液の吸収スペクトルを求めた。Table 4 The absorption spectra of the sample liquid before and after were determined.
その結果を下記第5表に示す。The results are shown in Table 5 below.
第5表
し、核酸塩基や糖単独には作用せず、ヌクレオチドにも
作用しないことが明らかである。From Table 5, it is clear that it does not act on nucleobases or sugars alone, nor does it act on nucleotides.
また、本酵素の作用するヌクレオシドの糖部分はリボー
スでもデオキシリボースでもよく、塩基部分も各種のも
のでよいことが判る。It is also understood that the sugar moiety of the nucleoside on which this enzyme acts may be either ribose or deoxyribose, and the base moiety may also be of various types.
(4)ラッカーゼ基質に対する特異性試験本酵素の7m
Mイノシン存在下におけるラッカーゼ様活性の基質特異
性を以下の通り調べた。即ち、イノシン7mMと共に下
記第5表に示す各種ラッカーゼ基質の1mMを含む試料
液に本酵素1ユニツトを添加して5分間放置し、上記酵
素添加上記第5表より、本酵素はイノシン存在下では各
種ラッカーゼ基質に作用することが判る。(4) Specificity test for laccase substrate 7m of this enzyme
The substrate specificity of laccase-like activity in the presence of M-inosine was investigated as follows. That is, 1 unit of this enzyme was added to a sample solution containing 7 mM of inosine and 1 mM of various laccase substrates shown in Table 5 below, and left for 5 minutes. It is found to act on various laccase substrates.
また、上記ラッカーゼ様活性の発現にはイノシンの他、
第4表に示したような各種のヌクレオシドオキシダーゼ
の基質となるヌクレオシドならば、いずれでもよいこと
が確認されている。In addition to inosine, the expression of the above-mentioned laccase-like activity also requires
It has been confirmed that any nucleoside can be used as long as it is a substrate for various nucleoside oxidases as shown in Table 4.
(5)温度及びpH試験
■ 温度安定性:
本酵素をリン酸緩衝液(pH6,0)100脱中にて1
5分間処理視した後、その残存活性を測定した。(5) Temperature and pH test ■ Temperature stability: This enzyme was dissolved in phosphate buffer (pH 6,0) for 100 min.
After being treated for 5 minutes, the residual activity was measured.
その結果は、第3図(横軸=温度、縦軸=残存活性)に
示す通りであり、本酵素は60℃で15分間安定である
ことが判る。The results are shown in Figure 3 (horizontal axis = temperature, vertical axis = residual activity), and it is clear that this enzyme is stable at 60°C for 15 minutes.
■ pH安定性:
本酵素をそれぞれのpHで37℃下に60分間処理し、
その後、pH6,0にて残存活性を測定した。■ pH stability: This enzyme was treated at 37°C for 60 minutes at each pH,
Thereafter, residual activity was measured at pH 6.0.
その結果は、第4図(横軸=pH,縦軸=残存活性)に
示す通りであり、本酵素はpH5〜6で安定であること
が判る。The results are shown in FIG. 4 (horizontal axis=pH, vertical axis=residual activity), and it can be seen that this enzyme is stable at pH 5 to 6.
■ 至適pH:
第5図(横軸=pH,縦軸=相対活性)に示す通り11
本酵素の至適pHは5〜6であった。尚、第5図中(1
)は酢酸緩衝液(μ=0.05)を、(2)はリン酸緩
衝液(μ=0.05)を示す。■ Optimal pH: 11 as shown in Figure 5 (horizontal axis = pH, vertical axis = relative activity)
The optimum pH of this enzyme was 5-6. In addition, in Figure 5 (1
) indicates acetate buffer (μ=0.05), and (2) indicates phosphate buffer (μ=0.05).
■ 至適温度:
本酵素の活性測定に用いる酸素電極は、40℃以上でそ
の精度が低下し、正しい測定ができない。■Optimal temperature: The accuracy of the oxygen electrode used to measure the activity of this enzyme decreases at temperatures above 40°C, making accurate measurements impossible.
40℃までの範囲では40℃で最も高い活性を示した。In the temperature range up to 40°C, the highest activity was shown at 40°C.
(6)分子量測定試験
セファクリルS−200(ファルマシア社製)カラム(
径2. 5c+nX長さ90cm)を用いたゲル清適法
により、本酵素の分子量を測定した。(6) Molecular weight measurement test Sephacryl S-200 (manufactured by Pharmacia) column (
Diameter 2. The molecular weight of this enzyme was measured by the gel clearing method using 5c+nX length 90 cm).
その結果、本酵素の分子量は130000と求められた
。As a result, the molecular weight of this enzyme was determined to be 130,000.
(7)等電点試験
キャリアーアンホライト(pH3,5〜10.5)を用
い、LKB社製焦点電気泳動装置を用いて、冷却(4°
C)下に48時間泳動を行なって、本酵素の等電点を求
めた。(7) Isoelectric point test Using carrier amphorite (pH 3.5-10.5), cooling (4°
C) Electrophoresis was performed for 48 hours to determine the isoelectric point of the enzyme.
得られた本酵素の等電点はpH5,3であった。The isoelectric point of the obtained enzyme was pH 5.3.
(8)阻害剤の影響試験
本酵素溶液(0,02U)を各種阻害剤の存在下ニ、p
H6,0,25℃、10分間イノシンニ作用させた後、
活性を測定した。(8) Inhibitor effect test This enzyme solution (0.02U) was tested in the presence of various inhibitors.
H6, 0, 25℃, after 10 minutes of inosinini action,
Activity was measured.
その結果を下記第6表に示す。The results are shown in Table 6 below.
上記第6表より、本酵素は、シアン化カリウム、アジ化
ナトリウム、N−ブロモコハク酸イミド等により阻害さ
れることが判る。From Table 6 above, it can be seen that this enzyme is inhibited by potassium cyanide, sodium azide, N-bromosuccinimide, and the like.
(9)紫外、可視吸収スペクトル分析
100mMリン酸緩衝液(pH6,0)中における本酵
素のスペクトル分析を行なった。(9) Ultraviolet and visible absorption spectral analysis A spectral analysis of the enzyme in 100 mM phosphate buffer (pH 6,0) was performed.
その結果を第6図に示す。The results are shown in FIG.
(10)金属含量
原子吸光法により測定した結果、本酵素中には鉄が含ま
れていることが確認されたが、モリブデン、銅、マンガ
ン、亜鉛は検出されなかった。(10) Metal content As a result of measurement by atomic absorption spectrometry, it was confirmed that this enzyme contained iron, but molybdenum, copper, manganese, and zinc were not detected.
(11)活性に及ぼす金属イオンの影響本酵素溶液(0
,02U)を各種金属イオンの存在下に、pH6,0,
25℃、10分間イノシンに作用させた後、活性を測定
して、各種金属イオンの本酵素活性に及ぼす影響を調べ
た。(11) Effect of metal ions on activity This enzyme solution (0
,02U) in the presence of various metal ions at pH 6.0,
After acting on inosine at 25° C. for 10 minutes, the activity was measured to examine the effects of various metal ions on the enzyme activity.
その結果を下記第7表に示す。The results are shown in Table 7 below.
第7表
(12)Km値
イノシンに対する見掛けのKm値を求めた結果、該Km
値は4.4X10−5Mであった。Table 7 (12) Km value As a result of determining the apparent Km value for inosine, the Km
The value was 4.4×10 −5 M.
(13)アミノ酸組成
本酵素を6N塩酸を用いて減圧下に24.48又は72
時間加水分解し、充分に塩酸を除去した後、0.09M
クエン酸緩衝液(p H2,2)に溶解させ、この溶液
について日本電子社製JLC200、A型自動アミノ酸
分析機を用いてアミノ酸の分析を行なった。(13) Amino acid composition This enzyme was prepared under reduced pressure using 6N hydrochloric acid at 24.48 or 72
After hydrolysis for a period of time and sufficient removal of hydrochloric acid, 0.09M
It was dissolved in a citrate buffer (pH 2.2), and the amino acids in this solution were analyzed using JLC200, Type A automatic amino acid analyzer manufactured by JEOL Ltd.
トリプトファン(Trp)の含量は、4.2NNaOH
にて110℃下に24時間加水分解後、同様にして測定
した。シスチン(Cys)の定量は、本酵素を過蟻酸酸
化後、塩酸分解を行なって分析した[S、 Moore
、 J、Biol、Chem、、 238. 235
(1963) )。The content of tryptophan (Trp) is 4.2N NaOH
After hydrolysis at 110° C. for 24 hours, measurements were made in the same manner. Cystine (Cys) was quantified by oxidizing the enzyme with performic acid and then decomposing it with hydrochloric acid [S, Moore
, J. Biol.Chem., 238. 235
(1963)).
結果を下記第8表に示す。The results are shown in Table 8 below.
第8表
(14)ディスク電気泳動
7%ポリアクリルアミドゲル(pH9,5) を使用シ
、デイビスの方法(J、B、Davis、 Ann、N
、Y。Table 8 (14) Disk electrophoresis using 7% polyacrylamide gel (pH 9,5) using the method of Davis, J. B., Davis, Ann, N.
,Y.
Acad、Sci、、 121 、 404 (198
4) )に従って、本酵素のディスク電気泳動を2本行
なった。一方は蛋白染色を、もう一方はlll1m単位
で切って活性測定を行ない、それぞれ泳動位置を調べた
。Acad, Sci., 121, 404 (198
4) Two disk electrophoresis cycles of this enzyme were performed according to (4)). One part was subjected to protein staining, and the other part was cut into sections of 1/1 m to measure the activity, and the electrophoretic position of each was investigated.
その結果、酵素蛋白は単一バンドを示し、その泳動位置
は活性の泳動位置と一致した。As a result, the enzyme protein showed a single band, and its migration position coincided with the active migration position.
以下、本発明酵素を用いた本発明分析法の実施例を示す
。尚、以下の各側において酵素としては、前記実施例3
で得られたヌクレオシドオキシダーゼYT−1精製標品
を用いた。Examples of the analytical method of the present invention using the enzyme of the present invention will be shown below. In each of the following cases, the enzyme used in Example 3 is
The purified nucleoside oxidase YT-1 sample obtained in .
実施例 4
4−アミノアンチピリン 23.4mg5%フ
ェノール 2mf25QmM
HEPES緩衝液 98 脱(p H7,5)
計 100 鵬上記
組成の発色液2.0鵬にヌクレオシドオキシダーゼ10
μΩ (0,35U)を加え、次いで種々の濃度のアデ
ノシン含有被検液0. 31TII2を加え、混合液を
30℃で20分間反応させた後、500nmの吸光度を
測定した。Example 4 4-aminoantipyrine 23.4 mg 5% phenol 2mf25QmM
HEPES buffer 98 Decomposition (pH 7,5) Total 100 Peng Coloring solution with the above composition 2.0 Peng and nucleoside oxidase 10
μΩ (0.35 U) was added, and then 0.5 μΩ of test solution containing adenosine at various concentrations was added. After adding 31TII2 and reacting the mixture at 30° C. for 20 minutes, the absorbance at 500 nm was measured.
その結果は第7図に示す通りである。図において縦軸は
吸光度を、横軸は被検液のアデノシン濃度(ミリモル)
を示す。The results are shown in FIG. In the figure, the vertical axis represents the absorbance, and the horizontal axis represents the adenosine concentration of the test solution (mmol).
shows.
第7図より、吸光度測定により被検液中のアデノシンを
簡便且つ良好に定量できることが判る。From FIG. 7, it can be seen that adenosine in the test liquid can be easily and favorably quantified by absorbance measurement.
実施例 5
4−アミノアンチピリン 2B、4DN−エチ
ル−N=(2−ヒドロキ
シ−3−スルフォプロピル)−3゜
5−ジメチルアニリン 178.7mg50m
Mリン酸緩衝液
−(pH6,0) 100 mQ計
100 脱上記
組成の発色液2. omcにヌクレオシドオキシダー
ゼ10μQ (0,35U)を加え、次いで種々の濃
度のイノシン、グアノシン、デオキシアデノシン含有被
検液0. 3mf2を加え、混合液を30℃で20分間
反応させた後、630r+mの吸光度を測定した。Example 5 4-aminoantipyrine 2B,4DN-ethyl-N=(2-hydroxy-3-sulfopropyl)-3°5-dimethylaniline 178.7mg50m
M phosphate buffer - (pH 6,0) 100 mQ meter 100 Coloring solution with the above composition 2. 10 μQ (0.35 U) of nucleoside oxidase was added to the omc, and then 0.0 μQ (0.35 U) of nucleoside oxidase was added to the test solution containing various concentrations of inosine, guanosine, and deoxyadenosine. After adding 3mf2 and reacting the mixture at 30°C for 20 minutes, the absorbance at 630r+m was measured.
その結果を第7図と同様にして、第8図(イノシン測定
結果)、第9図(グアノシン測定結果)及び第10図(
デオキシアデノシン測定結果)に示す。The results are shown in the same manner as in Fig. 7, and Fig. 8 (inosine measurement results), Fig. 9 (guanosine measurement results), and Fig. 10 (
Deoxyadenosine measurement results).
2等各図より、吸光度測定により被検液中の各ヌクレオ
シド量を簡便且つ良好に定量できることが判る。It can be seen from the 2nd grade figures that the amount of each nucleoside in the test liquid can be easily and favorably quantified by absorbance measurement.
実施例 6
4−アミノアンチピリン 23.4mgN−エ
チル−N−(2−ヒドロキ
シ−3−スルフオンロピル) −m
−トルイジン 171.3mgグリセ
ロール−2−リン酸φ2ナ
トリウム 1.76gMnS
O4−4〜6H2019,4mg50mM HEPE
S緩衝液
(pH7,5) 100 或計
100 戒上記組成
の発色液2.0戚にヌクレオシドオキシダーゼ10μQ
(0,35U)を加え、次いで種々の濃度の5′−ヌ
クレオチダーゼ含有被検液(シグマ社製、5’ −ND
コントロールE)0.1購を加え、次に基質である11
.5mM5′−アデニル酸(5’−AMP)溶液0.2
鴫を添加し、分光光度計にて単位時間当りの5550I
11の吸光度の増加を約5分間測定した。Example 6 4-aminoantipyrine 23.4 mg N-ethyl-N-(2-hydroxy-3-sulfonropyl) -m-toluidine 171.3 mg φ2 sodium glycerol-2-phosphate 1.76 g MnS
O4-4~6H2019, 4mg50mM HEPE
S buffer (pH 7,5) 100 or total
100 precepts Add 10 μQ of nucleoside oxidase to coloring solution 2.0 with the above composition.
(0.35 U), and then a test solution containing various concentrations of 5'-nucleotidase (manufactured by Sigma, 5'-ND
Control E) Add 0.1 ml, then substrate 11
.. 5mM 5'-adenylic acid (5'-AMP) solution 0.2
5550I per unit time using a spectrophotometer.
The increase in absorbance of 11 was measured for about 5 minutes.
その結果を第11図に示す。図において縦軸は1分間当
りの吸光度の増加値を、横軸は5′−ヌクレオチダーゼ
濃度(U/Q)を示す。The results are shown in FIG. In the figure, the vertical axis shows the increase in absorbance per minute, and the horizontal axis shows the 5'-nucleotidase concentration (U/Q).
第11図より、吸光度測定により被検液中のヌクレオチ
ダーゼ量を簡便且つ良好に定量できることが判る。From FIG. 11, it can be seen that the amount of nucleotidase in the test liquid can be easily and favorably quantified by absorbance measurement.
実施例 7
4−アミノアンチピリン 23,4mg5%、
フェノール 2 或MnSO4・
4〜6H2019,4mg50mM HEPES緩衝
液
(pH7,5) 98 11IQ計
100 脱上記
組成の発色液2. o+ncにヌクレオシドオキシダー
ゼ10μQ (0,35U)を加え、次いで種々の濃度
の3′−ヌクレオチダーゼ含有被検液(シグマ社製)0
.1mOを加え、次に基質である11.5mM 3’
−アデニル酸(3’ =AMP)溶液0.211Qを
添加し、分光光度計にて単位時間当りの505nmの吸
光度の増加を約5分間測定した。Example 7 4-aminoantipyrine 23.4 mg 5%,
Phenol 2 or MnSO4・
4-6H2019, 4mg 50mM HEPES buffer (pH 7,5) 98 11IQ meter 100 Coloring solution with the above composition 2. 10 μQ (0.35 U) of nucleoside oxidase was added to o+nc, and then a test solution containing various concentrations of 3'-nucleotidase (manufactured by Sigma) was added.
.. Add 1 mO, then 11.5mM 3' substrate
-Adenylic acid (3' = AMP) solution 0.211Q was added, and the increase in absorbance at 505 nm per unit time was measured for about 5 minutes using a spectrophotometer.
その結果を第11図と同様にして、第12図に示す。The results are shown in FIG. 12, similar to FIG. 11.
該図より、吸光度測定により被検液中のヌクレオチダー
ゼ量を簡便、迅速且つ良好に定量できることが判る。The figure shows that the amount of nucleotidase in the test solution can be easily, quickly, and satisfactorily quantified by absorbance measurement.
実施例、8
実施例6に示した発色液と同一組成の発色液に、ヌクレ
オシドオキシダーゼ10μQ (0,35U)及び人血
清0. 1mQを加え、次に5’ −AMP(11,5
mM)0.2TnQを添加し、分光光度計にて555n
mの吸光度の増加を測定することにより人血清中の57
−ヌクレオチダーゼ活性を測定した。Example 8 To a coloring solution having the same composition as the coloring solution shown in Example 6, 10 μQ (0.35 U) of nucleoside oxidase and 0.0 μl of human serum were added. Add 1 mQ, then 5'-AMP(11,5
mM) 0.2TnQ was added and 555n was added using a spectrophotometer.
57 in human serum by measuring the increase in absorbance of m.
- Nucleotidase activity was measured.
同一血清試料を用いて15回上記測定を繰返した結果は
下記第9表に示す通りである。The above measurement was repeated 15 times using the same serum sample, and the results are shown in Table 9 below.
第9表
第10表
上記表より本測定法によれば、人血清中の5′−ヌクレ
オチダーゼ活性を高い再現性をもって測定できることが
明らかである。From Table 9, Table 10, and the above table, it is clear that according to the present measurement method, 5'-nucleotidase activity in human serum can be measured with high reproducibility.
実施例 9
実施例8と同様にして人血清5検体について、5′ −
ヌクレオチダーゼ活性を測定した。Example 9 In the same manner as in Example 8, 5′ −
Nucleotidase activity was measured.
また、比較のため同人血清検体に対して従来知られてい
る酵素法(C,L、M、Arkesteijn、 J、
Cl1n。For comparison, a conventional enzymatic method (C, L, M, Arkesteijn, J.,
Cl1n.
Chem、Cl1n、B1och+;m、、 Vol、
14.p155−158(197B) :]を行なって
、同酵素活性を測定した。Chem, Cl1n, B1och+;m,, Vol,
14. p155-158(197B):] was performed to measure the enzyme activity.
得られた結果(U/Q)を下記第10表に対比して示す
。The obtained results (U/Q) are shown in Table 10 below.
上記表、より本測定法によれば、従来の測定系が複雑で
、反応開始前に30分程度の予備反応が必要である等の
欠点を有している酵素法に代って、人血清中の5′−ヌ
クレオチダーゼ活性を、非常に簡単な操作で、高感度に
しかも短時間で測定できることが明らかである。According to the table above, this measurement method can be used to replace the enzyme method, which has drawbacks such as the conventional measurement system being complicated and requiring a preliminary reaction of about 30 minutes before starting the reaction. It is clear that the 5'-nucleotidase activity in the protein can be measured with high sensitivity and in a short time using a very simple operation.
実施例10
種々の濃度のイノシンを含む100mMリン酸緩衝液(
pH6,0)2mf2に、1mMo−)ルイジン溶液1
mQを加え、次いでヌクレオシドオキシダーゼ10μQ
(0,35U)を添加し、37℃で15分間反応さ
せ、反応液の480 nmの吸光度を測定した。Example 10 100mM phosphate buffer containing various concentrations of inosine (
pH 6,0)2mf2, 1mMo-)luidine solution 1
Add mQ, then 10 μQ of nucleoside oxidase
(0.35 U) was added and reacted at 37° C. for 15 minutes, and the absorbance of the reaction solution at 480 nm was measured.
得られた結果を第13図に示す。図において縦軸は48
0 nmの吸光度を、横軸は反応液中のイノシン量(μ
モル)を示す。The results obtained are shown in FIG. In the figure, the vertical axis is 48
The absorbance at 0 nm is plotted on the horizontal axis, and the amount of inosine in the reaction solution (μ
mole).
該図より、被検液のイノシン含有量と吸光度との比例関
係を利用して、被検液中のイノシン量を良好に測定でき
ることが明らかである。From the figure, it is clear that the amount of inosine in the test liquid can be satisfactorily measured by utilizing the proportional relationship between the inosine content of the test liquid and the absorbance.
第1図は本発明酵素作用試験Iに従い、イノシンを基質
として本酵素による酸化反応を行なって得られる反応生
成物の高速液体クロマトグラフィーの結果を示す図であ
る。
第2図は本発明酵素作用試験Hに従い、イノシンを基質
としてフェノール及び4−アミノアンチピリンの存在下
に本酵素による酸化反応を行なって得られるキノンイミ
ン色素の発色度合と上記基質濃度との関係を示す図であ
る。
第3図は本酵素の温度安定性を調べた図である。
第4図は本酵素のpH安定性を調べた図である。
第5図は本酵素の至適pHを調べた図である。
第6図は100mMリン酸緩衝液(pH6,0)中おけ
る本酵素のスペクトル分析結果を示す図である。
第7図乃至第10図は実施例4及び5に従い、各種被検
液中のヌクレオシド量と吸光度測定値との関係を求めた
グラフである。
第11図及び第12図は実施例6及び7に従い、各種被
検液中のヌクレオチダーゼ量と吸光度測定値との関係を
求めたグラフである。
第13図は実施例10に従う測定結果(イノシン量と吸
光度測定値との関係)を求めたグラフである。
(以 上)
第
図
ノテンションタイム (脅)
第
図
イノシン11度(ナノモル)
第
図
H
第
図
第
図
イノシン′J農道
(ミリモル)
第
図
U
弘ヌクレオチターセ゛si度(I+I)3′−ヌクレオ
チダーセ゛511蔓(、lJg)第
図
O10
グアノシン:/居r<ミリモル)
第
図
テにキシアテンシンJi(ミリモル)
第13
図FIG. 1 is a diagram showing the results of high performance liquid chromatography of a reaction product obtained by carrying out an oxidation reaction with the present enzyme using inosine as a substrate according to the enzyme action test I of the present invention. Figure 2 shows the relationship between the degree of color development of a quinone imine dye obtained by carrying out an oxidation reaction with this enzyme using inosine as a substrate in the presence of phenol and 4-aminoantipyrine and the above substrate concentration according to enzyme action test H of the present invention. It is a diagram. FIG. 3 is a diagram showing the temperature stability of this enzyme. FIG. 4 is a diagram showing the pH stability of this enzyme. FIG. 5 is a diagram showing the optimum pH of this enzyme. FIG. 6 is a diagram showing the results of spectrum analysis of this enzyme in 100 mM phosphate buffer (pH 6.0). FIGS. 7 to 10 are graphs showing the relationship between the amount of nucleosides in various test liquids and the measured value of absorbance according to Examples 4 and 5. FIGS. 11 and 12 are graphs showing the relationship between the amount of nucleotidase in various test liquids and the measured absorbance value according to Examples 6 and 7. FIG. 13 is a graph showing the measurement results (relationship between the amount of inosine and the measured absorbance value) according to Example 10. (That's all) Diagram Notion Time (Threat) Diagram Inosine 11 degrees (nanomole) Diagram H Diagram Diagram Inosine 'J Farm Road (millimol) Diagram U Hironucleotidase degree (I + I) 3'-nucleotidase 511 vine (, lJg) Figure O10 Guanosine: /R < mmol) Figure
Claims (4)
、該ヌクレオシドと分子状酸素との反応によってヌレオ
シド−5′−アルデヒドを経てヌクレオシド−5′−カ
ルボン酸を生成するが、過酸化水素は副生しないことを
特徴とする新規ヌクレオシドオキシダーゼYT−1。(1) An enzyme that catalyzes the oxidation reaction of nucleosides, which produces nucleoside-5'-carboxylic acid via nucleoside-5'-aldehyde through the reaction of the nucleoside with molecular oxygen, but hydrogen peroxide is a secondary enzyme. A novel nucleoside oxidase YT-1 characterized in that it does not produce nucleoside oxidase.
系を被検液とし、酸化により発色する発色試薬と上記被
検液との混合物に請求項1に記載のヌクレオシドオキシ
ダーゼYT−1を作用させ、被検液のヌクレオシド量変
化に比例する上記発色試薬の発色度合を測定することを
特徴とする被検液の分析法。(2) A system containing or producing nucleosides is used as a test solution, and the nucleoside oxidase YT-1 according to claim 1 is allowed to act on a mixture of the test solution and a coloring reagent that develops color by oxidation; A method for analyzing a test liquid, characterized by measuring the degree of color development of the above-mentioned coloring reagent, which is proportional to a change in the amount of nucleosides in the test liquid.
シドを遊離させる酵素反応系及びヌクレオシドを分解さ
せる酵素反応系から選択される請求項(2)に記載の分
析法。(3) The analytical method according to claim (2), wherein the test liquid is selected from a sample containing nucleosides, an enzyme reaction system that liberates nucleosides, and an enzyme reaction system that degrades nucleosides.
レオシド遊離酵素反応系であり、上記人血清中の5′−
ヌクレオチダーゼ活性が測定される請求項(2)に記載
の分析法。(4) The test solution is a nucleoside-releasing enzyme reaction system containing human serum and nucleotides, and the 5'-
The analytical method according to claim (2), wherein nucleotidase activity is measured.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63196632A JPH0272873A (en) | 1988-02-04 | 1988-08-05 | Nucleosideoxidase and analyzing method utilizing the same |
US07/425,217 US5156955A (en) | 1988-02-04 | 1989-02-01 | Nucleoside oxidase and assay method utilizing same |
EP89902177A EP0353311B1 (en) | 1988-02-04 | 1989-02-01 | Nucleoside oxidase and analytical method using same |
DE68920659T DE68920659T2 (en) | 1988-02-04 | 1989-02-01 | NUCLEOSIDE OXIDASE AND ANALYTICAL PROCEDURE. |
PCT/JP1989/000105 WO1989007137A1 (en) | 1988-02-04 | 1989-02-01 | Nucleoside oxidase and analytical method using same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63-25462 | 1988-02-04 | ||
JP2546288 | 1988-02-04 | ||
JP63196632A JPH0272873A (en) | 1988-02-04 | 1988-08-05 | Nucleosideoxidase and analyzing method utilizing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0272873A true JPH0272873A (en) | 1990-03-13 |
JPH0544273B2 JPH0544273B2 (en) | 1993-07-05 |
Family
ID=12166691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63196632A Granted JPH0272873A (en) | 1988-02-04 | 1988-08-05 | Nucleosideoxidase and analyzing method utilizing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0272873A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003156432A (en) * | 2001-11-22 | 2003-05-30 | Toshiba Corp | Optical waveguide type biochemical sensor |
JP2003207445A (en) * | 2002-01-16 | 2003-07-25 | Toshiba Corp | Portable inspecting apparatus and system |
JP2003279479A (en) * | 2002-01-16 | 2003-10-02 | Toshiba Corp | Optical waveguide type glucose sensor and optical waveguide type glucose measurement method |
JP2005037403A (en) * | 2002-01-16 | 2005-02-10 | Toshiba Corp | Optical waveguide type glucose sensor |
-
1988
- 1988-08-05 JP JP63196632A patent/JPH0272873A/en active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003156432A (en) * | 2001-11-22 | 2003-05-30 | Toshiba Corp | Optical waveguide type biochemical sensor |
JP2003207445A (en) * | 2002-01-16 | 2003-07-25 | Toshiba Corp | Portable inspecting apparatus and system |
JP2003279479A (en) * | 2002-01-16 | 2003-10-02 | Toshiba Corp | Optical waveguide type glucose sensor and optical waveguide type glucose measurement method |
JP2005037403A (en) * | 2002-01-16 | 2005-02-10 | Toshiba Corp | Optical waveguide type glucose sensor |
Also Published As
Publication number | Publication date |
---|---|
JPH0544273B2 (en) | 1993-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4810640A (en) | Method of quantitative assay for 1,5-anhydroglucitol | |
KR870000509B1 (en) | L-glutamic acid oxiase (h202-generating),its production and analytical method therefor | |
EP0016845B1 (en) | Method and test composition for the determination of a substrate for xanthine-oxidase, including a novel xanthine-oxidase and method for the preparation thereof | |
US6153419A (en) | Method for quantitative determination of 1,5-anhydroglucitol | |
JPH0272873A (en) | Nucleosideoxidase and analyzing method utilizing the same | |
JPS6279780A (en) | Quantitative determination of 1,5-anhydroglucitol, enzyme used therefor and production thereof | |
EP0353311B1 (en) | Nucleoside oxidase and analytical method using same | |
JPH0373276B2 (en) | ||
EP0101653B1 (en) | Leucine dehydrogenase and a process for production thereof | |
JPH03219900A (en) | Method for measuring freshness of fishes or shellfishes | |
JP3031517B2 (en) | Novel ascorbate oxidase, its production method and its use | |
JP3490184B2 (en) | Novel N-alkylglycine oxidase, method for producing the same, reagent for quantifying Nε-carboxymethyllysine using the enzyme, and method for quantifying the same | |
JP3778603B2 (en) | Sorbitol oxidase, its production method and its use | |
FR2517698A1 (en) | METHOD FOR DETERMINING ETHANOLAMINE | |
JP3929576B2 (en) | Microorganism producing enzyme acting on phosphorylated 1,5-anhydroglucitol, enzyme produced by the microorganism, and method for quantifying phosphorylated 1,5-anhydroglucitol using the same | |
JP3007059B2 (en) | Method for determination of formaldehyde oxidase and substance or enzyme | |
JPH0428353B2 (en) | ||
JPH0616703B2 (en) | Thermostable peroxidase, method for producing the same, and analytical reagent using the enzyme | |
JPS5828283A (en) | Improved method for producing choline oxidase | |
JPH0670763A (en) | New choline-decomposing enzyme | |
JPH0644878B2 (en) | Bile acid measurement reagent | |
JPH0212557B2 (en) | ||
JPH02227073A (en) | Putrescine : pyruvate transaminase | |
JPS63207385A (en) | D-selenocystine decomposition enzyme and production thereof | |
JPS6368079A (en) | Novel 3alpha-hydroxysteroid dehydrogenase and production thereof |